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1. INTRODUCTION 
 
1.  ASTHMA 
1.1 EPIDEMIOLOGY 
Asthma is a disease of global importance as demonstrated by statistics relating to morbidity, 
mortality and associated healthcare expenditures (Brusselle et al. 1994). Approximately 300 
million people worldwide suffer from asthma, with increasing prevalence among people in 
most European countries. This trend is also evident in less developed countries and has been 
attributed to implementation of westernised lifestyles. Estimations predict that if this rising 
trend persists, an additional 100 million people will be afflicted with asthma by 2025 (Masoli, 
M.,et al. 2005 ). In the UK, approximately 5.4 million people are currently receiving 
treatment for asthma, representing one of the highest prevalence in the world. The incidence 
is higher in children and affects approximately 1 in 10, thus making this the most common 
chronic childhood disease in the UK, while mortality statistics indicated 1100 deaths 
attributed directly to asthma in 2009 (UK, A. Facts for journalists). Economic costs including 
hospital admissions, physician visits and pharmacological expenditures associated with the 
condition rank as one of the highest among chronic diseases (Bahadori, K., et al.2006)  
 
1.2 DEFINITION AND DIAGNOSIS   
 
Asthma is a disease with heterogeneous symptoms that can broadly be defined as a disorder 
of the conducting airways resulting in variable degrees of airflow obstruction that is reversible 
or non-reversible.  
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Figure 1.1   Right: healthy bronchus with clear airway; Left: inflamed, contracted smooth muscle      
(https://upload.wikimedia.org/wikipedia/commons/4/4a/Asthma_attack-illustration_NIH.jpg) 
 
 
The pathology of asthma is characterized by airway inflammation, alterations in airway 
smooth muscle growth and structural changes throughout the conducting airways which 
contribute to airway hyper responsiveness (AHR), mucosal inflammation and airway 
remodeling (Patterson et al. 2014). 
Asthma attacks are characterized by wheezing, cough, shortness of breath and chest tightness 
or any combination these and are reported in 90% of patients with asthma.  
However, these symptoms alone are not sufficient for diagnosis and more information about 
chest symptoms during different time points of the day, cough or shortness of breath during 
stress or after exercise is required for a differential diagnosis.  
 A family history of asthma and/or other allergic disease is also a useful diagnostic marker as 
asthma clusters in families, as well as worsening of symptoms in response to known triggers 
such as pets, house-dust mites, tobacco smoke or cold/humid air (Barnes et al. 2008).  
 
 
1.3 CLASSIFICATION 
 
Asthma has been grouped under various phenotypes and broadly divided into two forms, 
namely allergic and non-allergic asthma (Hassan et al. 2012). Allergic asthma is the most 
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common form of disease and is characterised by the presence of allergen-specific IgE usually 
indicated by the positive skin-prick test (SPT) to the panel of common environmental 
allergens. In contrast, non-allergic asthma is not driven by allergen although patients can 
present symptoms of allergic disease such as eosinophilic infiltration in the lung. 
Alternatively, a number of asthmatic patients have robust neutrophilic responses in the 
airways which is indicative of a more severe, steroid-resistant asthma phenotype or viral-
induced asthma exacerbation. In the accordance with these subsets, Woodruff et al. classified 
two unique molecular phenotypes based on the extent of Th2 inflammation; groups were 
defined as ‘Th2-high’ and ‘Th2 low’ with the latter known as poor responders to current 
asthma therapies (Woodruff et al. 2016). 
 
 
1.4 DISEASE MODELS OF ALLERGEN –DRIVEN ASTHMA  
 
Asthma pathophysiology is associated with airway inflammation; however multiple immune 
pathways are implicated in the activation of inflammatory components that bring about 
disease symptoms. Most of the research on cellular components and mechanisms of asthma 
has been focused on allergic asthma induced by environmental allergens. These findings are 
largely derived from studies of allergen-challenged atopic patients and analyses of biopsies, 
bronchial alveolar lavage (BAL), sputum and serum and ex vivo studies of clinical samples.    
In addition, murine models of allergic airway inflammation were used to investigate the role 
of cellular and molecular components in vivo: genetically modified mouse strains, mono-
clonal antibodies that block a singular component of the immune system or local gene 
overexpression are tools in asthma research. The most common mouse model of acute allergic 
airway inflammation is based on systemic sensitisation with Ovalbumin (OVA) as surrogate 
allergen together with an adjuvant aluminium hydroxide (alum). This is followed by multiple 
allergen challenges of the airways over 1-2 weeks, although variation of this treatment regime 
has been described including the route of delivery of the sensitising allergen and the number 
of challenges administered (Conrad et al. 2009). Other allergens that are commonly used 
include complex aeroallergens, e.g. cockroach extract, ragweed or house dust mite (HDM) 
which is utilised in this study. House dust mite is a common cause of allergic symptoms and 
asthma worldwide. The mites gut contains potent digestive enzymes (proteases) that persist in 
their feces and exoskeleton which are major inducers of allergic reactions such as wheezing 
and allergic reactions (Subramaniam et al. 2016) . 
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The house dust mite (Dermatophagoides pteronyssinus) are microscopic organisms that thrive 
in warm and humid houses with lots of human and animal skin. The protein substances that 
are excreted of the mites are inhaled or touch the skin upon which the body reacts with IgE 
antibody production. On following exposures, IgE antibodies can cause the release of 
histamine that leads to swelling and irritation of the upper respiratory passages. 
 
 
2 ASTHMA EXACERBATION 
 
2.1 EPIDEMIOLOGY AND CLINICAL CONSEQUENCES OF 
EXACERBATION 
 
Asthma exacerbations are more common in female than in male patients, and the higher 
prevalence of asthma in adult women contrasts with the higher prevalence of asthma in male 
children (Bjornson und Mitchell et al. 2000).  
Loss of control of symptoms can result in an exaggerated lower airway response to 
environmental triggers which leads to acute exacerbation of the disease (Johnston et al. 2007). 
Allergens, environmental pollutants, medication, cold/humid air, exercise and occupational 
irritants have been identified as triggers, however virus infections account for the large 
majority of severe episodes. Respiratory viruses (RVs) such as respiratory syncytial virus 
(RSV) are the most frequently detected viruses during exacerbations but also other viruses 
such as coronavirus, adenovirus, bocavirus, influenza and parainfluenza. It has been also 
shown that bacterial pathogens, such as H. influenza, S. pneumoniae, P. aeruginosa and M. 
catarrhalis increase the secretion of mucus, which is found in infected asthma or COPD 
patients by characteristic goblet cell hyperplasia and often result in exacerbation of the disease 
(Bisgaard et al. 2002). Further, the group of Bisgaard has shown that colonization of the 
hypopharyngeal region of neonates with S.pneumoniae, H.influenzae, or M.catarhalis or a 
combination of these organisms leads to increased risk for recurrent wheeze and asthma early 
in life. 
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          Figure 1.3                 Human respiratory pathogens associated with asthma exacerbations.      
            
Exacerbations are often events in the clinical course of COPD, associated with significant 
mortality. Exacerbation of COPD increased the percentage of mortality in patients from 8% to 
23% after 1 year of follow up. Exacerbations are correlated with accelerated loss of lung 
function and quality of life and increased healthcare costs (Seemungal und Wedzicha et al. 
2015).  
 
2.2 INFECTION AND ALLERGIC ASTHMA  
A fundamental question which Green el. et  has asked is why infections that usually manifest 
as a self-limiting mild disease of upper airways in healthy individuals cause severe lower 
respiratory tract infections and initiate asthma exacerbations in  individuals (Green et al. 
2002) 
Studies have highlighted a strong association between atopy, allergen exposure and 
respiratory bacterial infections with an increased risk of exacerbations of asthma in children 
and adults (Bisgaard et al. 2007a). In addition, research indicates that atopic sensitisation and 
respiratory viral infections in early life may interact to increase the risk of asthma inception 
and development. Notably, Bisgaard et al. evaluated hypopharyngeal samples of a 
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community-based cohort of 321 neonates at 1 month of age of. 21% of the infants were 
colonized with M.catarrhalis, S.pneumoniae, H.influenzae, or a combination of these 
organisms, and bacterial infection was significantly associated with persistent wheeze, or 
acute severe exacerbation of wheeze. Blood eosinophils counts and total IgE at the age of 4 
years were significantly increased in children neonatally colonized with a single bacterium or 
several microbes at the same time. Interestingly, specific IgE was not significantly affected in 
these children. Asthma was significantly increased and the reversibility of airway resistance 
after ß2-agonist administration at 5 years  and was decreased in colonized children as 
compared to non-colonized children (Bisgaard et al. 2007a). 
 
 
3.  M. CATARRHALIS INFECTION 
 
M. catarrhalis is a gram-negative, aerobic, oxidase-positive diplococcus bacterium that was 
first described in 1896 (Frosch et al. 1896). The organism is also known as Micrococcus 
catarrhalis, Neisseria catarrhalis, and Branhamella catarrhalis (Berk et al. 1990). Currently, 
it is considered to belong to the subgenus Branhamella of the genus Moraxella. Previously, 
M.catarrhalis was associated with no significant pathogenic consequences and were 
considered as a saprophyte of the upper respiratory tract (Gordon J.E et al. 1921).  
Until recently, the complex mechanisms of colonization and pathogenesis of M.catarrhalis 
were unknown due to the limited research activities. However, research efforts have increased 
over the past decade and various bacterial components have been isolated, characterized and 
identified as possible vaccine antigens.  
After years of confusion and misidentification, M.catarrhalis is receiving attention as a 
pathogen that causes morbidity and mortality. The bacterium often causes infections in young 
children, is frequently associated with respiratory tract infections in adults causing lung 
disease and in rare cases can even cause systemic infections. Furthermore, the resistance to 
antibiotics suggests that the incidence of these infections may continue to rise (Karalus et al. 
2000). 
Most studies of the immune response against human infection with M.catarrhalis focused 
primarily on systemic immune responses. However, the bacterium is primarily responsible for 
local infections of the mucosal surfaces. Therefore, future studies that evaluate human 
mucosal immunity may identify responses that are critical for prevention of colonization or 
the resolution of infections caused by M.catarrhalis (Karalus et al.2000). 
 INTRODUCTION 7 
 
3.1 M. CATARRHALS IN RESPIRATORY EPITHELIAL CELLS  
 
M. catarrhalis is a mucosal pathogen that may cause childhood otitis media, exacerbate 
asthma and trigger chronic obstructive lung disease (COPD). M.catarrhalis can invade 
bronchial epithelial cells, type II pneumocytes and primary small airway epithelial cells. 
M.catarrhalis invasion is dependent on cellular microfilaments and bacterial viability. 
Invasion of lung epithelial cells results in colonization and infection of the respiratory tract 
despite recognition by cell surface Toll-like receptor 2 (TLR2) and the intracellular 
surveillance molecule NOD1 (Seybold et al. 2007). It has been shown that M.catarrhalis 
adheres to epithelial cells of different mucosal tissues such as the nasopharynx and lungs and 
consequently, strong adhesion to epithelial cells is considered an important virulence trait of 
M.catarrhalis. Upon epithelial cell adhesion, bacteria express various pro-inflammatory 
genes, including those encoding for tumor necrosis factor- (TNF-), Interleukin Il-1ß, IL-6 
and IL-17 and chemokines CXCL1, CXCL2 and CCL20. These genes are known to be 
induced during acute infection by many bacterial pathogens and serve as a general alarm 
signal to initiate a strong immune response by the host. (Stefan P. 2010 ; Brusselle et al. 
1994). 
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4. THE IMMUNOLOGY OF ASTHMA 
 
 
Figure 1.2             Left: sensitization phase; Right: challenge phase of asthma  
    
Direct and indirect cDCs and epithelial cells express pattern-recognition receptors and can be activated directly 
by allergens. In response to allergens, lung epithelial cells produce chemokines such as CCL2 and CCL20 that 
attract immature pre-cDCs. Activated epithelial cells produce cytokines ( IL-1α, GM-CSF, IL-25, IL-33 and 
TSLP) and danger signals (ATP and uric acid) that favor the maturation of CD11b+ cDCs Activated lung 
CD11b+ cDCs then migrate to the draining mediastinal lymph nodes, where they induce TH2 and TH17 
responses. Migration is stimulated by IL-13 produced from ILC2 cells. Some helper T cells start producing IL-21 
and adopt a follicular helper T cells to induce IgE in B lymphocytes. In the lymph nodes, DCs receive help from 
basophils to activate TH2 responses. Taken from/modified :  Bart N Lambrecht, nature immunology , 2014 
 
 
Asthma is a very common disease that affects many people, men and women, young and old, 
worldwide. The major hallmark for asthma was T-helper type 2 (Th2) cell for a very long 
time. However, recent discoveries show that it is not always the case; also neutrophils which 
are IL-17 dependent contribute to the inflammation. They are usually controlled by T-helper 
type 17 (Th17) cells or by a newly discovered cell subset conferring the innate lymphoid cells 
type 3 (ILC-3) which also secrete IL-17 (Lambrecht and Hammad et al.2014). 
One of the early steps in allergic sensitisation is the generation of antigen-specific T cell 
responses, which are initiated by antigen-presenting dendritic cells (DC) (Goke et al. 2001). 
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Dendritic cells survey the lungs for invading pathogens and inhaled antigens in a DC-network 
located under the airway epithelium. Epithelial cells provide adjuvant signals in response to 
antigens that direct the migration and maturation state of DCs and T cells (Thornton, E.E. et 
al. 2012). DCs then migrate to the draining lymph node to present antigen and costimulatory 
signals to the T cells, which then in turn migrate to the airways to secrete cytokines and other 
mediators. These mediators direct the asthmatic response in the lung, for example IL-5 which 
promotes airway eosinophilia whereas IL-17 recruits neutrophils to the lung. The magnitude 
of both acute and chronic asthma attacks correlates with the number of eosinophils and 
neutrophils present in the lung and with the increase in bronchial hyper- responsiveness. From 
biopsy studies, it is known that infiltrating eosinophils degranulate at the subepithelial site, 
but also deeper in the interstitium (Dooper et al. 1993). Presumably, toxic eosinophil derived 
products such as eosinophilic cationic protein and major basic protein are able to induce 
shedding of epithelial cells, as seen in adults with asthma, where sloughing of the epithelium 
has occurred. IL-13 seems to be involved in goblet cell metaplasia and mucus production 
(Barrett and Austen 2009). In addition, allergen-specific, long-lived memory T cells are 
generated and react immediately and strong upon repetitive contact with an immunological 
known antigen.     
 
 
4.1 T HELPER CELLS AND ASTHMA  
 
Over the last years T helper 2 (TH2) cells, a subpopulation of CD4
+
 T cells emerged to play 
an important role in asthma pathogenesis. By releasing a number of typical cytokines, these 
cells direct a number of inflammatory events that lead to the formation of the disease. The 
major cytokines induced in asthmatic patients are IL-4, IL-5 and IL-13 (Luger et al. 2009).  
IL-4 upregulates the fate-determining transcription factor GATA-3 in naïve T helper cells, 
which in turn is essential for the initial differentiation and expansion of allergen-specific Th2 
cells.  
Furthermore, IL-4 can also play a significant role in triggering the basis for IgE-mediated 
allergic reactions. Beside its effects on differentiating B cells, IL-5 can work on eosinophils 
by effecting their recruitment, activation, differentiation and survival in the periphery 
suggesting that this cytokine plays a central factor in regulating airway eosinophilia in asthma 
(Rosenberg et al. 2007). While, IL-4 and IL-5 mainly acts on immune cells, IL-13 can act on 
airway epithelial cells and smooth muscle cells, where is mediates mucus production, 
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subepithelial fibrosis, and the development of AHR (Wills-Karp 2004). By secreting these 
three cytokines, Th2 cells exert on asthma pathogenesis on the level of T cells, B cells, and 
structural cells. It has been further studied in mouse models of experimental asthma the 
importance of these factors and demonstrated that allergic airway inflammation or AHR could 
not be induced in mice deficient for IL-4 , IL-13 nor animals lacking the IL-5 receptor  
(Brusselle et al. 1994). Although these results were clear and promising, the clinical 
approaches towards asthma therapy by neutralizing IL-4, IL-5 and IL-13 did not progress to 
clinical trials (Wenzel et al. 2007). 
Additionally, over the last few years Th9 and Th17 T helper subtypes were identified, which 
are also involved in asthma pathogenesis. The participation of Th17 cells in asthma has been 
first shown in 2001 revealing high amounts of IL-17 in plasma samples and increased IL-17 
mRNA levels in the pulmonary tissue of asthmatic patients (Wong et al. 2001). In 2008, this 
new T helper subset was identified as disease-mediating cells. It has been demonstrated that 
patients with severe asthma have highly activated Th17 cells in biopsies. In fact, these cells 
represented up to 20% of all infiltrating lymphocytes (Pene et al. 2008). These findings 
suggest that Th17 cells play a crucial role in the development of a severe asthma phenotype. 
Further studies in murine asthma model supported that these cells are glucocorticoid resistant 
(McKinley et al. 2008). Taken together, Th17 cells are key players of inducing allergic 
immune responses and are highly resistant against common treatment strategies with steroids. 
Although Th1 cells have shown to act as opponents to Th2 cells which counteract ongoing 
allergic immune responses, few studies also demonstrate a participation of interferon (IFN) 
in the development of AHR (Sel et al. 2007 and Cohn 1998). 
 
  
5. INNATE IMMUNITY 
 
Innate immunity is the first line of defence against infections. In many instances, innate 
immunity can eliminate microbes before the adaptive immune response is able to respond. 
Cells of the innate immune system comprise granulocytes, macrophages, natural killer cells, 
 cells and innate lymphoid cells (ILCs). 
In contrast, the evolutionary younger adaptive immune system allows a highly specific and 
efficient response to selected pathogenic structures. This intervention needs training and a 
tight regulation to prevent unnecessary damage (Janeway CA 2002). In case of reinfection, 
the immunological memory of the adaptive immune system enables a much faster and more 
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efficient response. The function of the adaptive immune system is mainly based on the 
activity of T and B cells and their interaction. Both are able to specifically recognise different 
pathogens via highly selective T or B cell receptors on their surfaces, which are generated by 
somatic rearrangement of the corresponding genes (Medzhitov R, and CA Janeway 2000). 
The innate immune system consists of cellular and soluble components, that recognize 
microbes and initiates responses that lead to their elimination. The principal effector cells of 
innate immunity are neutrophils, mononuclear phagocytes and natural killer (NK) cells (Biron 
et al. 1999) . These cells attack microbes that have reached epithelial barriers in order to 
invade the host tissue.  Each of these cell types play a distinct role in the response to 
microbes. Notably, macrophages and NK cells secret cytokines that activate phagocytes and 
stimulate a sequelae of soluble mediators and cellular reactions, leading to inflammation. 
Inflammation consists of recruitment and activation of leukocytes and several plasma proteins 
into the site of infection and elimination of infectious agents (Mayer-Scholl et al. 2004).  
Phagocytes, including neutrophils and macrophages are cells whose primary function is to 
identify, ingest and destroy microbes. Neutrophils, also called polymorphnuclear leukocytes, 
are the most abundant population of circulating white blood cells and mediate the earliest 
phases of inflammatory responses. The nucleus of a neutrophil is segmented into three to five 
connected lobules. Neutrophils are produced in the bone marrow and arise from a common 
lineage with mononuclear phagocytes (Mayer-Scholl et al. 2004). 
Macrophages and their circulating precursors, called monocytes, play a central role in innate 
and adaptive immunity and are important effector cells for the elimination of microbes. 
Bacteria taken up by macrophages reach the phagosome which will then fuse with the 
lysosome resulting in acidification of phagolysosome which usually kills the bacteria 
(Underhill und Ozinsky et al. 2002). 
     
 
5.1 RECRUITMENT OF LEUKOCYTES TO SITES OF INFECTION  
 
The early local reaction of innate immunity is the inflammatory response, in which leukocytes 
are recruited to the site of antigen and activated to eradicate the respiratory infection. The 
function of inflammation is to combat invading microbes or eliminate antigen by bringing 
activated effector cells into contact with foreign antigens in tissues. Inflammation is initiated 
by cytokines, especially IL-1 and TNF, chemokines that act on endothelial cells to recruit and 
activate various types of immune cells. 
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The composition of inflammatory leukocytes within tissues changes with time from 
neutrophil rich to mononuclear cell rich, which is a reflection of both, change in the 
recruitment of specific cell types and short life span of neutrophils. Macrophages that are 
recruited to sites of infection are activated by microbial products and by NK cell-derived IFN 
to phagocytose and to kill microbes. During respiratory inflammation, a variety of systemic 
cytokines are produced that enhance the ability of the innate immune system to clear the 
foreign antigen and which in rare cases may induce systemic tissue injury or death. These 
changes are mediated by the endocrine actions of cytokines and are collectively described as 
the acute phase response or the systemic inflammatory response syndrome (Annual Review of 
Immunology 2002).  
 
 
5.2  TUMOR NECROSIS FACTOR (TNF)  
 
5.2.1 ROLE OF TNF- IN INFECTIONS AND IN ASTHMA    
 
TNF-is the most widely studied pleiotropic cytokine of the TNF superfamily. TNF- is an 
important cytokine of the innate immune response, which plays a key role in the immediate 
host defence against invading microorganisms before activation of the adaptive immune 
system (Locksley RM et al. 2001). It is principally produced by macrophages in response to 
activation of membrane-bound pattern-recognition molecules, such as Toll like receptors, 
which detect common bacterial cell-surface products, such as LPSs, lipoproteins or flagellin. 
TNF-is produced by several cells, including monocytes, dendritic cells, B cells, CD4+ T 
cells, neutrophils, mast cells and eosinophils, and stromal cells, ie, fibroblasts, epithelial cells, 
and smooth muscle cells. TNF-is initially produced as a biologically active, 26-kd, 
membrane-anchored precursor protein (membrane TNF-which is subsequently cleaved by 
TNF-converting enzyme to release a 17-kd protein. This protein forms biologically active 
homodimers that act on the ubiquitously expressed TNF-receptors 1 and 2. This receptor-
ligand interaction causes intracellular signalling without internalization of the complex, 
leading to phosphorylation of IB and thus activation of the nuclear factor kB (p50-p65) 
heterodimer, which then interacts with the DNA chromatin structure to increase transcription 
of proinflammatory genes, such as IL1ß, IL6, IL8 and TNFitself. The response to TNF-
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activation is balanced by shedding of the extracellular domain of the TNF- receptors 
(Brightling et al. 2008). The primary role of TNF is the regulation of immune cells. It has 
been discovered that TNF is identified as a mediator of endotoxin poisoning, and plays a role 
in septic shock. In these acute cases, monoclonal anti-TNF antibodies are of high therapeutic 
value (Thavarajah et al. 2009a).     
TNF plays a key role in response to infection. In the response to bacteria, TNFR1 mediates 
the activation, recruitment, and functional efficacy of immune cells and the formation of 
granuloma. Both TNFR1 and TNFR2 play a role not only in the control of viral and protozoal 
infections via apoptosis, but also for the pathology associated with these infections. TNF 
mediates numerous biological effects, including fever, shock, tissue inflammation and 
increase in acute phase proteins. TNF targeted therapy provides disease-modifying treatment 
and relief to patients suffering from rheumatoid arthritis, inflammatory bowel disease and 
other autoimmune condition. A growing number of applications are being explored, including 
treatment of refractory asthma. Treatment of this severe form of asthma however has been 
accompanied by a growing number of reported side effects, with reactivation of tuberculosis 
which belongs to one of the most severe unwanted side effects. 
Thus, the beneficial effects may be counteracted by pulmonary side effects including 
infections, pulmonary nodules, chronic fibrosis and exacerbation of lung disease. It is still 
questionable if discontinuing TNF-target therapy via the side effects would be a future target.  
(Thavarajah et al. 2009b). 
 
The contribution of TNF-to inflammatory responses in asthmatic airways was supported by 
observations that TNF-mRNA  and protein levels were increased in the airways of patients 
suffering from asthma (Ying et al. 1991b). Importantly, inhalation of recombinant TNF- to 
normal individuals led to the development of AHR and airway neutrophilia (Thomas et al. 
1995a). The mechanisms driving TNF- induced AHR have not been fully understood. AHR 
could be caused by a direct effect of TNF-on airway smooth muscle (ASM), or indirectly 
by the release of the cysteinyl leukotrienes C4 and D4 (Huber et al. 1988). In addition to its 
effects on AHR, TNF- is a chemoattractant for neutrophils and eosinophils, increases the 
cytotoxic effect of eosinophils on endothelial cells, is involved in activation of T cells, and 
increases epithelial expression of adhesion molecules such as intracellular adhesion molecule 
1 (ICAM 1) and vascular cell adhesion molecule (VCAM). 
In general, TNF- has been related to severe refractory asthma via several properties, 
including recruitment of neutrophils, induction of glucocorticoid resistance, myocyte 
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proliferation, and stimulation of fibroblast growth and maturation into myofibroblasts by 
promoting TGF-ß expression (Desmouliere et al. 1993; Sullivan et al. 2005). 
In addition to promoting airway inflammation and AHR, TNF- might play a central role in 
airway remodelling in severe refractory asthma 
 
 
Figure 1.4           Role of TNF- in the pathogenesis of asthma  
TNF- has many effects on the respiratory system. It can cause the recruitment of proinflammatory cells and 
affects the airway remodelling and induces typical asthma symptoms. Inhaled recombinant human TNF-a has 
been demonstrated to cause a decrease in forced expiratory volume and increased neutrophil and eosinophil 
recruitment.  (Christophor Brightling, mike Berry, J allergy Clin Immunol 2008) 
 
 
5.3 INTERLEUKIN 6 IN RESPIRATORY INFECTION AND ASTHMA  
 
Interleukin 6 (IL-6) has a broad effect on many cells including those of the immune system 
and often displays hormone-like characteristics that affect homeostatic processes. IL-6 is 
produced by innate immune cells such as macrophages, dendritic cells, mast cells, neutrophils 
and by some CD4 effector T cells which stimulate immune response during infection or tissue 
damage leading to inflammation. It could be also secreted by non- leukocytes such as 
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endothelial cells, epithelial cells and fibroblasts. IL-6 is responsible for stimulating acute 
phase protein synthesis and supports the growth of B cells and is antagonistic to regulatory 
cells. Together with colony-stimulating factors, IL-6 also stimulates the production of 
neutrophils from bone marrow progenitors. In adaptive immunity, IL-6 can stimulate the 
growth of B lymphocytes that are differentiated into antibody producers. IL-6 has context-
dependent pro- and anti-inflammatory properties and is regarded as a prominent target for 
clinical intervention. IL-6 is often induces together with the pro-inflammatory cytokines TNF-
 and IL-1 in many inflammatory states and have been recognized as targets of therapeutic 
intervention. Circulating IL-6 plays an important role in the induction of acute phase 
reactions. In acute inflammatory responses Xing el. et. has revealed that endogenous IL-6 
plays a crucial anti-inflammatory role in both local and systemic acute inflammatory 
responses by controlling the level of proinflammatory, but not anti-inflammatory cytokines 
and that these anti-inflammatory activities by IL-6 cannot be compensated for by IL-10 or 
other IL- 
6 family members (Xing et al. 1997). Moreover, it is evident that IL-6 is not only a 
proinflammatory marker, but also an active factor that contributes to the pathogenesis of 
different inflammatory diseases such as rheumatoid arthritis. High levels of IL-6 in serum 
have been found in asthmatic patients (Yokoyama A et al. 1995). An important question to be 
addressed is whether the presence of IL-6 in the lung is associated with altered lung function. 
In obese asthmatic patients, the increased levels of IL-6 in serum also correlated with 
impaired lung function (Dixon AE et al. 2006). Together, it is indicated that the presence of 
IL-6 in the lung airways correlates with an impaired lung function in different subsets of 
asthmatic patients, and suggests that IL-6 can be directly involved in the pathogenesis of 
asthma.  
 
6. ADAPTIVE IMMUNITY  
 
When naïve T cells are activated in the presence of IL-4, it induces T cell differentiation into 
the Th2 subset, which then generates large amounts of IL5, IL-4 and IL-13. These cytokines 
will activate eosinophils, mast cells and basophils which plays an important role in allergic 
reactions. Additionally, Th2 cytokines promote B cells to produce IgA and IgE isoforms of 
antigen specific antibody. IL-4 and transforming growth factor (TGF)-ß results in the 
generation of Th9 which will produce IL-4 and IL-13 similar to Th2 cells as well as IL-9. 
Both Th2 and Th9 subsets are upregulated by the activation of GATA-3. In response to 
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extracellular bacteria, immune cells will generate large amounts of both TGF-ß and IL-6 an 
additional stimulation of IL-21 and IL-23 will differentiate the naïve T cells into Th17 cells 
under the differential control of a transcription factor called ROR. This T cell subset will 
then produce large amounts of IL-17 which can activate neutrophils to kill many bacteria and 
fungi. Not all T cell differentiation is pathogenic specific. Some T cell differentiation occurs 
to support immune functions to all infection responses. In response to pathogens IL-21 and 
IL-27 are generated, naïve T cells via the induction of transcription factor Bcl-6 home to B 
cell follicles in SLOs. Once there Tfh cells express cytokines and costimulatory molecules to 
assist in the germinal centre reaction of B cells.  
The danger of immunopathology is characterized by persistent immune responses which 
produces a regulatory subset of T cells (Tregs) that dampens the inflammatory processes. 
Tregs can be produced directly from thymic selection (natural Tregs) as well as differentiated 
(induced Tregs ) unlike other T cell subtypes under the influence of environmental factors 
such as TGF-ß and retinoic acid. The suppressive activity of Tregs is mediated by the active 
expression of the transcription factor FoxP3. 
Finally it is important to note the immunological diseases that occurs when any of these 
processes occur in an unyielding or in the absence of a traditional immunological/pathogenic 
trigger. The role of Th1 and Th17 has been elucidated in multiple autoimmune diseases such 
as type 1 diabetes and multiple sclerosis (Komiyama et al. 2006). Additionally the robust of 
Th2/Th9 responses has been linked to allergy and asthma.  Tissue fibrosis and loss of 
functional organ architecture is resulted via unresolved Th2 and Th17inflammation (Puel et 
al. 2010). Collectively, the appropriate immune homeostasis for the host depends on the 
regulation of activation and immune suppression.  
 
 
6.1 INTERLEUKIN 17A 
 
Interleukin 17 is a pro-inflammatory cytokine induced by IL-23 and produced by T-helper 
cells. The function of IL-17 is to bind to a type I cell surface receptor called IL-17R. IL-17 
mediates the delay type reactions by increasing chemokine production in various tissues. 
Signaling from IL-17 recruits neutrophils and monocytes to the site of inflammation in 
response to invasion by pathogens. The most important role of IL-17 is the involvement in 
inducing and mediating proinflammatory cytokines. IL-17 has been described to act 
synergistically with TNF and IL-1 in promoting inflammation and the production of other 
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cytokines such as IL-6, G-CSF, TGF-ß which has many functions, such as airway remodeling. 
IL-17 is able also to induce the production of chemokines (including IL-8, GRO- and MCP-
1) which attracts other cells including neutrophils but not eosinophils. IL-17 function is also 
essential to a subset of CD4+ T-Cells called T helper cells (Th17) cells. 
  
Interleukin 17 has six members in the (IL-17) cytokine family, including IL-17A, IL-17B, 
IL17C, IL17D, IL17E and IL-17F. IL-17A and IL-17F are well understood in the biological 
function and regulation and have a similar protein structure. They play protective roles in host 
defense against certain pathogens at epithelial and mucosal barriers. Aujela SJ el.et. has 
showed that IL-17A and IL-17F are important for the clearance of the extracellular bacteria 
Kelebsiella pneumoniae, which infects the lung (Aujla et al. 2008). Ishigame  et al.  has also 
demonstrated that when these both cytokines are defective the animals become more sensitive 
to the S.aureus which demonstrates the largely redundant function of these cytokines 
(Ishigame et al. 2009). As already mentioned IL-17F has been shown to have a 
proinflammatory role in asthma which has been well characterized both in vitro and in vivo. 
IL-17F is clearly expressed in the airways of asthmatics and its expression level correlates 
with disease severity. Moreover, a coding region variant (H161R) of the IL-17F gene is 
inversely associated with asthma and encodes an antagonist for the wild-type IL-17F. IL-I7F 
activates the MAP kinase and utilizes IL-17RA and IL-17RC as its receptor.  IL-17F is 
produced from several cell types such as Th17 cells, basophils and mast cells and shows a 
wide tissue expression pattern including the lung (Kawaguchi et al. 2009) . has showed that 
overexpression of IL-17F gene in the airway of mice is associated with airway neutrophilia,  
induction of many cytokines, an increase in airway hyperactivity and mucus hypersecretion 
(Kawaguchi et al. 2009). Collectively, IL-17F plays an important role in allergic airway 
inflammation and have important therapeutic implications in asthma.  
Although asthma is classically associated with eosinophilia and Th2 cytokines, some patients 
show a neutrophil-predominant disease with an absence of Th2 cytokines. In particular, 
patients with more severe forms of asthma seem to have neutrophilic inflammation with less 
reversible airway obstruction and a mixed Th1 and Th17 cytokine milieu (McKinley et al. 
2008). The role of IL-17 and Th17 cells in allergic asthma has been fully elucidated, as this 
cytokine has been shown to be sometimes involved in protection and in other cases (most 
cases) in the development of inflammation or immune pathology . Thus, IL-17 can be pro or 
anti-inflammatory cytokine depending on the time point of neutralization or administration of 
IL-17 for example, IL-17A plays a protective role in asthma only during the challenge phase 
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(Schnyder-Candrian et al. 2006). Another study showed that high exposure to diesel exhaust 
particles is associated with both exacerbated asthma symptoms and increased serum 
concentrations of IL-17A in children with atopic asthma (Brandt et al. 2013). Severe forms of 
asthma are characterized by increased airway remodelling. IL-17A contributes to remodelling 
by promoting fibroblast proliferation and by counteracting the anti-inflammatory role of 
Tregs in some experimental asthma models driven by HDM or ozone. (Zhou et al. 2015). In 
mice and humans, IL-17 can also cause direct contraction of bronchial smooth muscle cells 
and thus cause bronchial hyperreactivity (BHR) in the absence of neutrophilic inflammation. 
It remains unclear where  in asthmatic airways, IL-17A and IL-17F are produced. There is 
also a complex interaction between Th17 cell driven asthma and tumor-necrosis factor (TNF). 
Pulmonary and systemic amounts of TNF are increased in patients with severe steroid-
resistant asthma, although some studies have not confirmed this (70-79 the immunology of 
asthma). In an adoptive transfer model of Th17 OVA-specific T cells, neutralization of TNF 
led to reduced neutrophilic influx in the lung tissue and airspaces which was associated with 
improved lung function parameters such as lung compliance but not airway hyper-resistance. 
In clinical trials, the results of TNF blockade have also been variable (Berry et al. 2006a). 
Thus, it is still unclear whether TNF blockade in IL-17-rich neutrophilic asthma improves 
also steroid responsiveness. 
 
 
6.2 TH1 IN INFECTIONS AND ASTHMA 
 
Th1 cells,  typically mediate antiviral, antibacterial and in some cases also antifungal immune 
responses, by activating macrophages through the production of IFN, whereas cytokines 
secreted by Th2 cells are responsible for immunity against worms and the production of IgG 
and IgE, the recruitment of eosinophils and clearance of extracellular parasites.  
It has been well accepted that the decrease in microbiological burden which started in the 
beginning of the 20
th
 century caused an increase in atopic diseases and particularly asthma. 
This observation was later stated as the hygiene hypothesis (Strieter et al. 2002). Decreased 
exposure to pathogens during the early postnatal development skews the immune system 
towards Th2 response. Recently, this hypothesis was complemented by the discovery of 
different regulatory T cells (Tregs) which play a crucial role in dampening Th2 driven 
inflammation (Rautava et al. 2004). Commensal bacteria of the airways and the gut influence 
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the Th1/Th2 balance in the lung via the induction of Tregs (Atarashi und Honda 2011), also 
via secretion of short chain fatty acid (Wong 2006).  
The role of Th1 cells in asthma remains still controversial. Moreover, studies could not show 
airway hyperresponsiveness after adoptive transfer of OVA specific Th1 cells, other groups 
were able to induce AHR (Shaw et al. 2005). However, Th1 and Th2 responses may even act 
in combination to augment each other’s activity to induce airway inflammation and AHR 
(Ford et al. 2001). It has been demonstrated in a mouse model of allergic asthma that Th1 and 
Th2 cells were recruited together to the airway after sensitization with the model antigen 
OVA. However, Th1 cells were not only predominantly found early after the challenge their 
presence seems moreover to be a prerequisite for the recruitment of Th2 cells to the airways 
(Randolph et al. 1999).  
Observations were different concerning the function of Th1 cells in mucus hypersecretion, as 
one feature of bronchial asthma. Cohn et al showed that the adoptive transfer of antigen-
specific Th1 cells induced much less mucus than Th2 cells, mucus hypersecretion was totally 
absent in OVA challenged mice (Cohn et al. 1998). 
 At least the typical Th1 cytokine IFN-has already been shown to play a role in the 
development of AHR and in aggravating inflammatory events in asthma. Nevertheless, more 
studies are required to fully elucidate the role of Th1 cells and especially of IFN- in asthma 
pathology (Vock et al. 2010a). 
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2. AIMS OF THE STUDY 
 
Bacterial infections such as M.catarrhalis, Haemophilus influenza and streptococcus 
pneumonia are main triggers of asthma exacerbations. While Th17-mediated inflammation is 
clearly involved in the asthmatic responses, it is unknown whether M.catarrhalis infection 
triggers pulmonary Th17 immune responses and thus exacerbates pathogenesis of this disease. 
Besides IL-17, we also wondered whether epithelial-derived TNF- which has been identified 
as an initiator and regulator of Th17 immunity also plays a role in M. catarrhalis induced 
asthma excacerbations.  
Given that bronchial epithelial cells are the primary site of M.catarrhalis infection, it may be 
hypothesised that M.catarrhalis infection of the airway epithelium induces TNF- and thus 
provided a link between infection and Th17 driven allergic inflammation.  
 
In this study, our aims are to:  
 To study the induction of TNF- to M.catarrhalis airway infection. 
 To study in a mouse model of M.catarrhalis infection and HDM-induced allergic 
airway disease the effects on TNF- and Th17 mediated immune responses.  
 Define a mechanistic role for M.catarrhalis-induced TNF- in Th-17 induced 
exacerbation of allergic airway disease.    
 To determine the time point of M.catarrhalis infection on the augmentation of allergic 
airways disease (AAD). 
 To study the interaction between TNF- and Th17 in the exacerbation of allergic 
airway inflammation.  
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3. MATERIAL 
 
3.1. ANTIBODIES  
 
3.1.1. UNCONJUGATED   
 
-IL-6 PE capture beads    BD Biosciences,Sane Jose,CA 
-TNF PE capture beads    BD Biosciences 
-IL-1ß PE capture beads    BD Biosciences  
-IL-17 PE capture beads    BD Biosciences  
-IL-5 PE capture beads    BD Biosciences  
-IL-13 PE capture beads    BD Biosciences  
-IFNPE capture beads    BD Biosciences  
- mouse IL-6 (clone MP5-20F3)   Berlin Max Planck Institute 
-mouse TNF- (clone MP6-XT22)   Berlin Max Planck Institute 
 
3.1.2 CONJUGATED 
 
-CD4-V450(RM4-5)    BD 
-CD8a-V500 (53-6.7)    BD 
-CD16/CD32 (Fc block)   BD 
-CD25-PE-Cy7 (PC61.5)    eBioscience, San Diego, USA 
-CD11b-Phycoerythrin (PE)   eBioscience 
-CD45-APC      eBiolegend  
-CD3-FITC      BD, 
-Ly6C-V450      eBioscience 
-Ly6G-V500     Biolegend San Diego, USA 
-IL-5-PE      eBioscience 
-IL13-AlexaFluor 647    eBioscience  
-IFN-PerCP-Cy5.5     Biolegend  
-FoxP3-AlexaFlour 700    eBioscience  
-IL17-AlexaFlour 700    eBioscience  
-TCR-FITC     eBioscience  
-IL-6 PE      BD Biosciences  
-TNF PE      BD Biosciences  
-IL-1ß PE      BD Biosciences  
-IL-17 PE      BD Biosciences  
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-IL-5 PE      BD Biosciences 
-IL-13 PE      BD Biosciences Sane Jose, CA 
-IFN PE      BD Biosciences  
-mouse IgE (biotinylated)    BD Pharmingen NJ, USA 
-mouse IgG1 (biotinylated)    BD Pharmingen NJ, USA 
 
 
3.2 CHEMICALS 
 
 
99,8%       Sigma-Aldrich,Steinheim 
Aqua dest      Braun AG, Melsungen  
Agarose      Sigma- Aldrich, Steinheim 
Albumin bovine (BSA)    Sigma- Aldrich, Steinheim 
Ampicillin      Sigma- Aldrich, Steinheim 
ß-Mercaptoethanol (ME)    Biomol, Hamburg 
BSA Albumin Fraction V    Serva Elektroph, Heidelberg  
BM blue, POD Substrate    Roche, Mannheim 
Brefeldin A      Sigma-Aldrich Steinheim 
Chloroform 99%     J.T Baker  
Clicks RPMI      Biochrom, Berlin 
Collagenase D     Roche, Switzerland 
Complete Protease-Inhibitor Tablets   Roche, Switzerland  
DiffQuick®      Dade-Behring, Marburg 
DNase I      Roche, Switzerland 
DNA loading day 6×     Fermentas, Switzerland 
DNA away      M&P  
Dulbecco’s Phosphate Buffered Saline  Biochrom , Berlin 
Eosin G      Merck, Darmstadt 
Erythrocyte lysis buffer    Sigma-Aldrich, Steinheim 
Ethanol,absolute     Merck, Darmstadt 
Ethidiumbromid 1% (1mg/ml)   Roth, Karlsruhe 
Fetal Calf Serum     Greiner, Frickenhausen 
Hämatoxilin II, (Gill)     Biochrom, Berlin 
Ionomycin      Sigma-Aldrich, Steinheim 
Isofluran      Baxter, Erlangen 
Isopropanol      Roth, Karlsruhe 
Ketamin 50 mg/ml     Inresa GmbH, 
Non-essential amino acids    PAA, Austria 
Penicillin G/Streptomycin 100× solution  Thermo Fischer Sc. 
Phosphate Buffered Saline (PBS)   Biochrom, Berlin 
Phorbol 12-myristate 13-actetate (PMA)  Sigma, Steinheim 
Phosphate buffered saline (PBS)   Biochrom, Berlin 
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2-Propanol      Sigma, Steinheim 
RNase away
®
      M&P  
RNase A      Biozym Scientific GmbH, Oldendorf 
Rompun 2%      Bayer, Leverkusen 
Protease Inhibitor Cocktail Tablets Complete Roche, Switzerland 
Streptavidin/phosphate    Sigma, Steinheim 
Sodium Phosphate (Na2HPO4)   Merk, Darmstadt  
Sodium carbonate (NaHCO3)   Merk, Darmstadt 
Sulferic acid (H2SO4)     Merk, Darmstadt 
Saponin      Sigma-Aldrich, Steinheim 
Schiff’s Reagent     Roth, Karlsruhe 
Tween 20       Roth, Karlsruhe 
TRIS_HCl      Invitrogen 
Trypan blue      Gibco 
 
 
3.3 KITS 
 
IFN ELISA: Due Set ELISA mouse IFNg 
FoxP3-Fixation Kit     eBioscience 
Rotor-Gene SYBR
® 
Green PCR Kit   Qiagen, Hilden 
RNeasy
®
 Mini Kit(50)    Qiagen, Hilden 
RNase-Free DNase Set    Qiagen, Hilden 
RevertAid RT Reverse Transcription Kit  Thermo Fisher Scientific, Jdstein 
Cytometric Bead Array (CBA) Mouse/Rat soluble 
Protein master Buffer Kit      BD 
 
 
3.4 LABORATORY EQUIPMENT AND CONSUMABLES 
 
AriaIII Cell Sorter     Becton Dickinson, Heidelberg 
Braun Vasofix
®
Safety Braunüle G18 grün  Roth 
Biosphere
®
Plus safe Seal Micro Tubes  Sarstedt, Nümbrecht 
Casy® Cell Counter     Schärfe Systems 
Cell culture dish (150×20 mm, 100×20 mm,) Becton Dickinson, Heidelberg 
Cell culture plate (96-, 48-, 24-well flat bottom, 96- well round bottom)    
       Greiner/Coster, Frickenhausen 
Colombia Agar with 5% Blood   BD 
CryoTube
TM
 Vials     Thermo Fisher Scientific 
Cuvettes, Gene Pulser,  
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0.4cm (Nr. 165-2088)    BioRad 
ELISA plates      Thermo Fisher Scientific 
ELISA reader      Thermo Fisher Scientific 
Filtertippes (10µl, 100µl, 1000,µl)   Starlab, Hamburg 
GasPak
TM
 EZ Campy Counter system red BD 
Incubator      Heraeus, Hanau 
Hamilton Pipette     Hamilton 
House dust mite (HDM)    Greer, USA 
Heating block TCR 200    Roth, Karlsruhe 
Hypodermic needle 25G, 26G and 27G  BD Microlance 
Megafuge 1.0 R/ Biofuge Pic (Rotors ‘2704/’3328),1700 rpm equals 470g 
        Heraeus, Hanau 
Maxi-Sorp plates     Thermo Fisher Scientific 
Microscope BX51     Olympus 
Microwave      Sharp 
Nanodrop ND- 1000 Spectrophotometer  PeqLab 
Nylon cell stainer     BD Falcon,,NJ, USA 
Nylon mesh      GE Health care 
Object slide over slip     Menzel 
Object slides      Menzel 
PAA       Pasching  
Pasteur pipette     Brand  
PCR cycler      Biometra 
Reaction cups, 1.5 and 2 ml    Eppendorf 
Reaction tubes, 15 and 50ml    Greine 
Rotor-Gene Strip Tubes & Caps   Star Lab, Hamburg 
Rotor Gene 3000
®
     LTF 
Sterile Filter, 100 mm     BD 
Sterile filter, 24 mm     BD 
Sephadex coloms     GE Healthcare 
Sintilation counter     Life technologies 
Whatman paper        
Schleicher+Schüll 
 
 
3.5 MEDIA; BUFFERS AND SOLUTIONS 
 
Cell lysis buffer per 5×10
7
 cells or 1 tail tip: 
500µl TNE (see below), 7.5 µl proteinase K (10mg/ml), 25 µl pronase E (10 mg/ml) and 
50 µl SDS solution (10%), freshly prepared. 
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Digestion medium: 
RPMI 1640, 10% FCS, 1×non-essential amino acid, Pen/Strep (100 U/ml final) 
, 1mg/ml Collagenase D (stock 50mg/ml, 1:50), 20 µg/ml DNase I (stock 10 mg/ml, 1:500)  
 
ELISA blocking solution   
1× PBS with 1% BSA 
 
Coating buffer: 
0.1 M NaHCO3, pH 8.2 
 
EM cell freeze medium: 
80 % feeder cell medium, 10 % DMSO 
 
FCS: 
Serum was inactivated by heating at 56 °C for 40 min, cooled to room temperature (RT) 
and filtered sterile 
 
HDM solution for sensitization of mice: 
100µgHDM in 50µl PBS per animal  
 
Anaesthetics (5×): 
10 ml ketamine (50 mg/ml)/3.125 ml Rompun in PBS. 
 
Restimulation medium: 
3 ml of RPMI per well with 50ng/mL PMA (stock 1 mg/mL , 1:20000 dilution), 750 
ng/mL ionomycin (stock 1 mg/mL, 1:1333 dilution), 5µg/ml Brefeldin A /stock 10 mg/mL, 
1:2000) 
 
RPMI culture medium: 
500ml medium supplemented with 10 % FCS, 5 ml non-essential amino acids, with L-
glutamine (2mM final), penicillin/streptomycin solution (100 U/ml final) 
 
Saponin buffer: 
0.2 % saponin (w/v) dissolved in PBS and 2 % FCS (v/v) added. 
 
ELISA washing buffer: 
PBS with 0.05% tween (g/v) 
 
TNE solution: 
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10ml 1M Tris (pH 8.0), 20 ml 5 M NaCl, 2ml 0.5 M EDTA diluted ad 1000 ml aqua dest.. 
and autoclaved. 
 
 
3.6 MICE AND CELLS  
 
Mice were used for asthma and infection experiments or for organ extraction. Animals 
were kept under specific pathogen free conditions (SPF) in individual ventilated cages 
(IVC) at 20 °C and artificial light dark cycles. Food and water were provided ad libitum. 
The following inbred mouse stains and bacteria were used. 
 
Mice  
 
C57BL/6J mice, wildtype   Jackson laboratories   
IL-17AF
-/- 
mice, C57BL/6   kprovided by Prof. Prinz, Hannover 
 
Bacteria  
Moraxella catarrhalis      human isolates, provided by Prof. 
Mutters, Marburg  
 
3.7 ENZYMES 
 
DNaseI                 Invitrogen 
Hot start DNA polymerase    Novagen 
Proteinase K      Qiagen 
RNase        Biozym Scientific GmbH 
 
 
3.8 OLIGONUCELOTIDES 
 
Primers for quantitive real-time PCR: 
 
L-32: 
L-32 forward   5’ GCA AGT TCC TGG TCC ACA AT 3’ 
L-32 reverse   5’ GGG ATT GGT GAC TCT GAT GG 3’ 
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mIL-17: 
mIL-17 forward            5’ AAG GCA GCA GCA ATC ATC CC 3’ 
mIL-17 reverse             5’ GGG TCT TCA TTG CGG TGG AG 3’ 
 
IFN: 
IFN forward    5’ GCT TTG CAG CTC TTC CTC AT 3’ 
IFN reverse    5’ GCA GGA TTT TCA TGT CAC CA 3’ 
 
IL-6: 
IL-6 forward     5’ CCG GAG AGG AGA CTT CAC AG 3’ 
IL-6 reverse    5’ CAG AAT TGC CAT TGC ACA AC 3’ 
 
 
3.9 SOFTWARE 
 
Adope illustrator CS3    Adobe 
Cell Quest Pro     Becton Dickinson 
FlowJo      Tree Star 
Cell
F
- Imaging Software    Olympus   
FCAP Array
TM
 software    BD 
Relevation
TM
      Dynex 
Rotor Gene Software      Qiagen 
 
 
3.10 STATISTICAL ANALYSIS  
 
Statistical calculation for asthma experiment was performed with 1 way ANOVA 
Analysis including the Bonferroni multiple Comparison Test. Associated data points were 
analysed by Grubb’s test to exclude significant outliers.  
(http://www.graphpad.com/quickcalcs/Grubbs1.cfm) 
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3.11 DATABASES AND ONLINE TOOLS 
 
Blast:      http://blast .ncbi.nlm.nih.gov/blast.cgi  
Ensemble mouse:              http://www.ensembl.org 
Primer design and analysis:  http://frodo.wi.mit.edu/primer3/ 
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4. METHODS 
 
4.1 CULTURE OF MORAXELLA CATARRHALIS  
  
For mouse infection experiments, 25 µl of a M. catarrhalis frozen aliquot were plated on 
Columbia agar plates and incubated at 37 °C overnight. The next day, the plates were 
washed off and suspended in sterile PBS. 
To determine the effect of infection, mice were inoculated i.n with 200 * 10^6 CFU per 
mouse in a final volume of 50µl of Moraxella catarrhalis 
 
4.2 INFECTION OF MICE WITH M. CATARRHALIS 
 
C57BL/6 mice and IL-17AF 
-/- 
mice were anesthetised with Ketamine/Rompun solution. 
Their neck slightly overstretched and 50µl of bacteria-in-PBS-solution was applied 
intranasally. Mice were killed after 2hs and on days 1, 4, 7 and 12 after infection, Blood, 
BAL and Lung were removed prepared and analysed as described. 
 
4.3. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) 
 
ELISA is a biochemical method of detecting and quantifying antibodies or antigens in a 
liquid sample which bind to a surface-bound capture antibody. In a second step an antigen-
specific detection antibody is bound onto the antigen that receives either another 
amplifying antibody which carries and enzyme such as horseradish peroxidise (HRP) or 
alkaline phosphatase (AKP) or is linked to the enzyme itself.  
The substrate for the enzyme causes a colour change which is detectible by photometric 
analysis. 
Systemic levels of HDM-specific IgG1 were determined by Elisa. MaxiSorp 96-well plates 
were coated with 50µg/ml HDM extract overnight at 4°C. samples were added the next day 
and incubated overnight at 4°C with the corresponding biotin-labeled anti-Ig antibody. 
Plates were washed and incubated with streptavidin-peroxidase for 30 min at RT.After 
development with substrate the reaction was sropped using H2SO4 and ODs. 
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4.4 SURFACE STAINING  
 
Lungs were cut into 2–5 mm pieces and incubated for 30 min at 37°C in the incubation 
medium (IM) (RPMI-1640 with L Glutamine and NaHCO3, 10% FCS, 16 non-essential 
amino acids , 100 mg/mL streptomycin,120 mg/mL penicillin supplemented with1 mg/mL 
Collagenase D and 20 mg/mL DNase I. The pre-digested lungs were minced through 100 
mm nylon cell strainer diluted with IM and centrifuged at 1700 rpm for 5 min. Cell pellets 
were resuspended in erythrocytes lysis buffer (8 g/L NH4Cl; 1 g/L KHCO3; 37,2 mg/L 
EDTA) and incubated at room temperature supplemented with 50 ng/mL PMA,750 ng/mL 
ionomycin and 10 mg/mL brefeldin A for 4 h.  T-cells extracellular staining was performed 
in PBS with 1%FCS and presence of BD Fc Block anti-CD16/CD32 (93) and fluorophore-
labelled antibodies. The following antibodies for extracellular T-cell staining was 
performed with anti-CD4-V450 anti-CD8a-V500 and anti-CD25-PE-Cy7; nature for 3–5 
mins. Then, cells were washed with IM, centrifuged and resuspended in IM.  
 
4.5 INTRACELLULAR CYTOKINE STAINING (ICS) 
 
After extracellular staining, T-cells were fixed with FoxP3-Fixation Kit and permeabilized 
with 0,3% Saponin, 1% FCS in PBS followed by an intracellular staining in presence of 
BD Fc Block anti-CD16/CD32  with the following fluorophore-labelled antibodies: IFNɣ-
PerCP-Cy5.5 ; IL-17-AlexaFluor 700 and FoxP3-AlexaFluor 700 ; IL-5-PE ; IL-13-
AlexaFluor 647 . Every staining included respective negative and isotype controls. 
Fluorescence signals were acquired by flow cytometry and analyzed using FACSDivaTM 
software. 
 
4.6  CYTOMETRIC BEAD ARRAY (CBA) 
 
Cytometric Bead array (CBA) is a flow cytometry application that allows users to quantify 
multiple proteins simultaneously. The BD CBA system uses the broad dynamic range of 
fluorescence intensity so that beads can be mixed and run simultaneously in a single tube. 
This method significantly reduces sample requirements and time to results in comparison 
with traditional ELISA and Western blot techniques. CBA Flex sets make it easy to build a 
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multiplex by following five simple steps. The finished assay can be acquired on a variety 
of dual-laser flow cytometers and analysed using FCAP
TM 
Array software. 
Broncho alveolar lavage (BAL) fluid and lung homogenate supernatants were tested for 
secreted cytokines such as IL-6, IL-1ß, TNF, IL-17 and IFNg by CBA flex assay. 
96-well plates U-bottom were coated with first antibody mixture (each well 1µl capture 
bead antibody pro cytokine). Next 50µl of samples or standard will be added to each well 
and incubated for 1 hour in dark. Second antibody mix will be then added and shacked for 
5 min, incubated for 2h in dark. After 2 hours centrifuge at 1200 rpm for 5 min. discard the 
supernatant, add 180µl wash buffer per well and measure using FACS Array Bioanalyzer.  
 
4.7 MOUSE MODEL FOR ADJUVENT- FREE ACUTE ALLERGIC 
ASTHMA 
    
The induction of allergic asthma is based on inflammatory reactions against an otherwise 
harmless allergen. For this model C57BL/6J wildtype and IL-17AF
-/-
 mice were exposed 
intranasally (i.n) to house dust mite extract (HDM, 100mg in 50 µL PBS) by weekly (days 
0,7,14, and 21) intranasal challenges of slightly anesthetized mice (i.p) with Ketamine/ 
Rompun. Two days after the last HDM challenges, mice were sacrificed and blood, 
bronchoalveolar lavage fluids (BAL) and lungs were collected for further analysis.  
  
 
 
                                     
 
                                    
 
 
 
Figure 2:    Challenge protocol for acute murine experimental asthma induced by house dust 
mite (HDM) . Numbers indicate days of treatment and analysis.  
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4.8 PREPERATION OF SERUM  
 
Mice were killed with Isoflurane. Blood was drawn from axillary blood vessels for serum 
antibody analysis. After clotting (45 mins at RT), serum was separated by centrifugation at 
4000 rpm for 20 minutes and adjacent quantification of cytokines by ELISA as described 
above. Meanwhile, serum samples were stored at -80 °C. 
 
4.9 BRONCHOALVEOLAR LAVAGE (BAL)  
 
After 48 hours after the last HDM/PBS application, BAL weas taken using a syringe filled 
with 1 mL of protease inhibitor diluted in PBS. The BAL was diluted 1:1000 for the 
cytospin analysis and the rest was frozen and used for the cytokine analysis. 
 
4.10 CYTOSPIN ANALYSIS  
 
10
5
 cells were washed in cold 2% FCS-PBS twice and diluted in 100 l of cold (PBS1% 
BSA).  All samples were kept on ice. Normal microscope slides were used and put together 
with a special filter for the cytospins, all were placed into appropriate slots in the cytospin 
with the cardboard filters facing the center of the cytospin. In case there were few cells 
available, about 100 l of cold PBS with 1% BSA aliquots were added into each well and 
spun for 1-2 minutes. This will serve to wet the filter and allow more cells to reach the 
slide. The lid of the cytospin was carefully placed over the samples and spinned at 
maximum speed for 1-3 minutes. The filters were removed from their slides without 
contacting the smears on the slides. Each slide was examined under the microscope to be 
sure that the cells have annealed properly.  The cells should appear to have normal 
morphology and should be lying flat on the slide.  For staining purposes, the cells should 
also be in a flat layer on the slide. 
The slides were left to dry overnight and afterwards stained with Diff – Quick staining. 
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4.11 LUNG EMBEDDING  
 
Proceeding the BAL, the left lung was disconnected from the rest of the organ close to the 
bifurcation of the lungs by using a thin thread. This part of the lung was frozen in liquid 
nitrogen and stored for RNA analysis.  
The right lung was then filled and thereby fixed with 6% paraformaldehyde (PFA). 
Fixation was completed by storing the lung in 6% PFA for 24 hrs. Subsequently, the lungs 
were embedded in 2 % agarose and cut into 6 mm thick pieces and embedded in paraffin 
wax. The embedding of the lungs was conducted in Marburg in the Institute of Pathology 
of the University Hospital Gieβen and Marburg. 
 
4.12 PREPERATION OF LUNG SLIDES  
 
The paraffin-embedded lungs were cut into thin slices of 3 µm thickness by using a 
microtome and placed onto object slides. 
  
4.13 HAEMATOXYLIN-EOSIN- (HE-) STAINING 
 
For examination of pathophysiological changes and lung damage induced by allergic 
asthma, lung slices were stained with haematoxylin and eosin. First, the samples were de-
paraffinated in xylol (2* 10 mins) before rehydration in descending alcoholic 
concentrations (each step 2*5 mins in 100 %- , 5 mins 96 %,- and 5 mins 70 %- ethanol). 
After rinsing with water, the slides were stained in haematoxylin for 3 mins. A resting step 
in water for 5 mins secured persistence of the blue staining in the tissue. Next, the samples 
were stained in eosin for 2 mins and rinsed again with water. 
Afterwards the tissue was dehydrated in different alcoholic solutions (1 min in 96 %-, 2-3 
mins in 100 % ethanol followed by 2x10 mins in xylol). Histomount
® 
was used to cover 
the samples with cover slides. 
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4.14 PERIODIC-ACID SCHIFF (PAS) STAINING  
 
Mucus production by goblet cells can be taken as a characteristic of the asthmatic lung as 
goblet cells are only rarely found in healthy tissue. The periodic-acid Schiff staining (PAS) 
makes these cells visible. Deparaffinated and rehydrated tissue slices (see section for HE 
staining) were incubated in 0, 5 % periodic acid for 10 mins and washed in water for 
another 3 mins. The samples were transferred into Schiff’s reagent for 15 mins followed by 
1 min incubation in haematoxylin. After a final rinsing step, the samples were dehydrated 
in alcoholic solutions (1 min each 70 %, 96 % and 100 % ethanol). 
After final 15 mins incubation in xylol, the object slides were covered. 
 
4.15 IMMUNOGLOBULINS  
 
For detection of HDM-specific IgG1 and IgG2c, Maxi-Sorp plates were coated with 
50µg/ml HDM extract in bicarbonate buffer (pH 9.6) overnight at 4 °C. Subsequently, 
coated wells were blocked with 1% w/V BSA in PBS for 2h at RT. After washing, serum 
samples (1:100) were incubated overnight at 4 °C, washed and incubated with the 
corresponding biotin-labelled anti-immunoglobulin antibody overnight at 4 °C. Plates were 
washed and incubated with streptavidin-peroxidase for 30 min at RT. After development 
with substrate, the reaction was stopped using H2SO4 and ODs were read at 450 nm.  
 
4.16 PREPERATION OF WHOLE LUNG HOMOGENATE 
 
M. catarrhalis infected mice were killed by a high dose of isoflurane. Lungs were perfused 
with PBS through the heart puncture, before lungs were removed. The organs were cut into 
small pieces and digested with 1 mg/ml collagenase D and 20 mg/ml DNase I in incubation 
medium for 30 mins at 37 °C. Tissue pieces were sieved through nylon filters and 
centrifuged at 1700 rpm for 5 mins. Cell pellets were resuspended in erythrocytes lysis 
buffer and incubated at room temperature for 3 mins. Then cells were washed with IM, 
centrifuged and resuspended in IM. The resulting cells was used for restimulation 
experiment. 
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4.17 LYMPHOCYTE RESTIMULATION  
 
For ex vivo analysis, cells were restimulated for 4 hrs with 50 ng/ml PMA and 750 ng/ml 
ionomycin. If intracellular cytokine staining was performed, 10 µg/ml of Brefeldin A 
which is a Golgi blocker, to enrich the amount of intracellular cytokine and prevent 
secretion.  
 
4.18 CYTOKINE DEPLETION BY ANTIBODIES 
 
For depletion experiments, WT mice were injected intraperitoneally (i.p) with 100µg anti-
IL-6 or anti TNF or an isotype control antibody,4 hours before M.catarrhalis infection. 
 
4.19 mRNA MEASURMENT BY QUANTITATIVE REALTIME PCR 
(QRT-PCR)  
 
This PCR technique is used to amplify and simultaneously quantify a specific target DNA 
by including a fluorescent probe or dye in the reaction. 
For analysis of the cytokine production of M.catarrhalis infected lung tissues, a Taqman
® 
-
PCR for IL-6, IFN and IL-17A was performed on an Rotor-gene Real-Time Analysis 
software 6.1 (Build 93). For RNA sample extraction, lung tissues were snap frozen and 
homogenization of the tissue was done by mortar and pestle (cooled to temp in liquid 
nitrogen bath). At the same time, transfer 600µl RLT buffer + 1% ß-Mercaptoethanol pro 
25mg tissue to be homogenized .Transfer the tissue to the pestle and grind until a layer of 
very fine dust is all that is left, Add 70% ethanol to the homogenized tissue, followed by 
RNA isolation via the „RNeasy Micro Kit®” according to the manufacturers instructions. 
The resulting RNA content was measured by photometric analysis; cDNA synthesis was 
performed using the “cDNA Maxima First Strand Synthesis Kit for RT-qPCR®“with oligo-
dT- Primers. 
The following PCR conditions were used for the detection of IL-6, IFN and IL-17 
expression: 
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The temperature profile was the following: 95°C 5 mins, 94 °C 20 secs, 45 repeats 60 °C 
20 secs, 72°C 20 secs, acquiring to Cycling A(FAM). Results were normalised to L32 as a 
housekeeping gene by the ΔΔct method as specified by Applied Biosystems. 
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5. RESULTS 
 
5.1 AIRWAY INFECTION WITH M.CATARRHALIS TRIGGERS LUNG 
INNATE AND ADAPTIVE IMMUNITY 
 
To investigate the association between M. catarrhalis lung infection and allergic airway 
response, we first established a murine infection model and assessed the course of infection 
and the type of immune response triggered by M. catarrhalis. Two hours after intranasal 
inoculation, bacterial infection was fully established and bacterial titers of the lung 
dropped massively at day 2 p.i. and were below the detection limit at day 6, indicating that 
M. catarrhalis is rapidly cleared in WT mice (Fig.1 A). Next, we performed a kinetic of 
the immune response after intranasal M. catarrhalis infection on the absence of allergic 
airway disease. Total and differential cell counts of the Broncho Alveolar Lavage (BAL) 
demonstrated that infection induced an early and strong immigration of granulocytes 
(neutrophils and eosinophils) at day 4 which was followed by an influx of lymphocytes at 
day7 after infection (Fig.1 B, C). Accordingly, high amounts of CXCL1, CXCL10 in the 
BAL coincides with the prompt appearance of neutrophils and may act as a feedback loop 
to further attract neutrophils, NK and T cells (Fig.1 D) 
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Figure 1    Characterization of M.catarrhalis induced immune responses. Immune analysis of 
infection was assessed in mice that only received M.catarrhalis (i.e not HDM). (A) Time course of 
bacterial recovery from lung homogenates. (B) Total BALF cell counts. (C) Differential cell counts. 
(D)  Secretion of CXCL1 and CXCL10. Data were from two independent experiments (n=8 mice 
per group).  ***P=0.001, **P=0.01, *P=0.05 (1 way ANOVA).   
 
As pulmonary colonization with M. catarrhalis has been shown to cause airway 
inflammation via the epidermal growth factor receptor (Slevogt H 2014), we performed a 
kinetic study of inflammatory cytokines in the BAL. While IL-6, TNF-and IL-1ß peaked 
at day 1 p.i and rapidly decreased to low levels by day 4, IFN- and IL17 amounts were 
highest at day 7 p.i. (Fig.2 A).      
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We next determined the effect of M. catarrhalis infection on the survival of these mice. 
We found that 50% of wt mice died between day1 and day 2 post infection (Fig.2 B) 
                                           
 
   
 
 
 
 
 
 
 
 
 
 
Figure 2    Characterization of M. catarrhalis induced immune responses. The profile of infection 
was assessed in mice that only received M.cat (i.e not HDM). (A) IL-6, TNF, IL-1ß, IL-17, 
IFNcytokines in the BALF of wt mice was measured at day 1,4,7 and 12 after intranasal 
administration of 10^
8
 CFU of M. catarrhalis. (B) Survival curve. Data were from two independent 
experiments (n=8 mice per group).  ***P=0.001, **P=0.01, *P=0.05 (1 way ANOVA).   
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Since IL-17 has been described as a key cytokine involved in the pathogenesis of infection 
triggered asthma, the frequency and the origin of IL-17 production was investigated. Due 
to the late occurrence of IL-17 in the BAL, we continued to analyse the mRNA expression 
of this cytokine in lung homogenates. Strong IL-17 expression was found at day 7 and 
correlated with the rise of IL-17
+
 CD4
+
 T cells at this time point (Fig.3 A, B ). The 
majority of IL-17 secreting cells in the lung were conventional CD4
+
 T cells (70%) which 
increased between day 7 to 15 p.i. and only a minor fraction of TCR + cells (14%) was 
positive for IL-17, (Fig. 3 C) 
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Figure 3 Analysis of IL-17 frequency and origin after M.catarrhalis infection  
(A) mRNA relative IL-17expression in lung tissue. (B) Lung lymphocytes from M.catarrhalis 
infected mice were analysed for the frequency of IL-17A at days 7 and 15. (C) IL-17A T cells at day 
7 after infection. Data were from two independent experiments (n=8 mice per group).  
***P=0.001, **P=0.01, *P=0.05 (1 way ANOVA).   
 
 
5.2 ANTI INFLAMMATORY ROLE OF IL-6 DURING M.CATARRHALIS 
INFECTION  
 
IL-6 is induced together with the proinflammatory cytokines TNF-and IL-1ß after 
M.catarrhalis infection. IL-6 is known to play an important role in the induction of acute 
phase reactions. However, whether it plays pro- or anti-inflammatory roles in local or 
systemic responses after M.catarrhalis infection remains unclear. In this experiment, the 
role of IL-6 in acute inflammatory responses was investigated in animal model by using 
monoclonal antibody against IL-6. We found that Ab-mediated neutralization of IL-6 
increased local and systemic TNF- as well as early IL-1ß and IL-17 in the BAL (Fig.4 A, 
B). Importantly, anti-IL-6 treatment resulted in enhanced mortality, demonstrating that IL-
6 exerts an anti-inflammatory function during pulmonary M.catarrhalis infection (Fig.4 
C). This reveals that IL-6 has an anti-inflammatory role as shown by the reduction of local 
and systemic inflammatory cytokine responses. 
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Figure 4 Anti-inflammatory role of IL-6 response to M.catarrhalis infection  
Cytokine measurement was assessed in mice that only received M.catarrhalis. (A) Mice were 
administered a rat anti-murine IL-6 (100µg;20F3 ) or an IgG1 control antibody i.p intraperitoneal 
before 4 hours of M.catarrhalis infection. BALF proinflammatory cytokines TNF-, IL-1ß, IL-6 
and IL-17. (B) Serum Proinflammatory TNF-a. (C) Survival. Data were from two independent 
experiments (n=8 mice per group).  ***P=0.001, **P=0.01, *P=0.05 (1 way ANOVA).   
 
 
5.3 PRO- INFLAMMATORY ROLE OF TNF ON M.CATRRHALIS 
INFECTION  
 
TNF- is a multifunctional cytokine of the immune system, involved in local and systemic 
inflammation. It has been discovered as a mediator of endotoxin poisoning, and plays a 
role in septic shock. So we wondered whether TNF- is the mediator of inflammation and 
mortality. It has been demonstrated previously by Stefan P.W.dem Vries that TNF- is 
upregulated after M. catarrhalis infection by human epithelial cells, to determine the 
source of TNF- after M.catarrhalis infection in our animals. Wt mice were infected with 
M.catarrhalis, after 4 and 24 hours of infection and supernatants of epithelial cells were 
tested for the secretion of TNF-by Cytometric Bead assay. As shown in Fig 4 high levels 
of TNF-were secreted by epithelial cells. To determine the role of TNF- pro or anti-
inflammatory cytokine after M.catarrhalis infection. We administered in vivo a TNF- 
blocking monoclonal antibody (aTNF-) and we found that the absence of TNF- 
decreased the recruitment of neutrophils at day 4 compared to WT infected mice.  
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Figure 5. The effect of anti TNF-on influx of cells after M.catarrhalis infection  
Infection was assessed in mice that only received M.catarrhalis. Mice were administered a rat anti-
murine TNF (100µg; MP6-XT22) or an IgG1 control antibody i.p intraperitoneal before 4 hours of 
M.cat infection. (A) TNF- expressed by Tracheal epithelial cell administration with 
M.catarrhalis. (B) Total BAL cell counts and differential cells (neutrophils and macrophages). 
 
 
Moreover, in contrast to IL-6, neutralization of TNF- resulted in local which (BAL) and 
systemic (serum) reduction of IL-6, IL-1ß and IL-17 and increased IgG1with subsequent 
protection against M.catarrhalis induced death of animals (Fig 6 A, B, C and D). 
Collectively, these results indicate that TNF- plays a proinflammatory role in inducing 
neutrophils and IL-6, IL-1ß and IL-17 cytokines leading to a pathogenic response to 
M.catarrhalis infection.  
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Figure 6 The effect of anti TNF-on cytokine secretion after M.catarrhalis infection  
The protein levels of IL-6, TNF- and IL-17 was measured after M.catarrhalis infection as 
indicated in different time points (A,B) BALF and Serum pro-inflammatory cytokines IL-6, TNF, 
IL-1ß and IL-17. (C) Survival. (D) Levels of HDM specific IgG1 and IgG2c antibody titers were 
measured by the Elisa technique. . Data were from two independent experiments (n=6 mice per 
group).  ***P=0.001, **P=0.01, *P=0.05 (1 way ANOVA).   
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5.4 PULMONARY INFECTION WITH M.CATARRHALIS AUGMENTS 
HDM INDUCED AIRWAY RESPONSES 
 
To determine the mechanisms underlying Moraxella catarrhalis induced exacerbation of 
asthma, we used a HDM asthma model which is clinically more relevant to humans. HDM 
is a common allergen associated with asthma, which is used to induce allergic airway 
phenotype.  
The established model of HDM induced in C57BL6/J mice were infected with M. 
catarrhalis intranasally after second exposure with house dust mite extract (HDM) on day 
8 through intranasal administration and monitored the ensuing allergic airway 
inflammation on day 23 (Fig.7 A). As expected, HDM exposure induced more robust 
BALF inflammation than did PBS treatment. Inflammatory cell infiltration was increased 
in the airways of mice infected during HDM exposure (Fig.7 B). HDM-triggered 
inflammation was dominated by enhanced neutrophilic, eosinophilic and lymphocytic 
infiltrates (Fig.7 C)  
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Figure 7 M.catarrhalis during HDM exposure increases neutrophilic and eosinophilic infiltrates 
to the airways (A) HDM asthma induction Protocol in, Intranasal. (B)Total BALF cell counts (C) 
Differential cell counts, Neutrophils, Eosinophils, Lymphocytes.  
 
Furthermore, the predominant sign of allergic asthma is lung inflammation and mucus 
production. Therefore, Lung slices were stained for mucus production by PAS staining and 
goblet cells. As visualized by PAS staining, PBS control mice had healthy lungs whereas 
the HDM allergic mice showed mucus-producing goblet cells within the lung epithelium 
However, M.catarrhalis infection during HDM exposure showed significantly increased 
airway inflammation, goblet cell hyperplasia and mucus production from the lung 
compared to HDM allergic group (Fig.8 A, B, and C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8 M.catarrhalis infection increases mucus production and airway inflammation during 
HDM exposure (A). Representitive PAS stained lung tissue sections from mice either PBS, HDM 
or HDM and M.catarrhalis infection. Scale bars, 200 µm.. (B) Goblet cell counts from lung tissue. 
(C)  Inflammation score. . Data were from two independent experiments (n=8 mice per group).  
***P=0.001, **P=0.01, *P=0.05 (1 way ANOVA).   
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5.5 T CELL PROFILE AND CYTOKINE PRODUCTION FROM MICE 
INFECTED WITH M.CATARRHALIS DURING HDM CHALLENGE 
 
M.catarrhalis is the bacterium most commonly isolated during COPD exacerbations.  We 
wondered whether M.catarrhalis may promote neutrophilic asthma by suppressing Th2 
mediated responses, and by inducing potent neutrophilic inflammation that is driven by 
Th17 responses. We compared HDM allergic mice with those that additionally infected 
with M.catarrhalis. In line with the increased lymphocytic infiltration in BAL, the 
concentration of IFN, IL-17 and the frequency of Th1, Th17 and Th2 were enhanced in 
lung tissue from mice infected during HDM challenge (Fig.9 A). 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 Frequency of T cells, BAL and Lung homogenates from infection during HDM 
challenge (A) WT mice were infected with 200× 10^6 CFU M.catarrhalis. Lungs were harvested 
on day 23. Homogenised and the cells were stained for CD4, IFN, IL-17A, IL-5 and IL-13. 
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Numbers indicate in the percentage of positive cells located the respective quadrant. . Data were 
from two independent experiments (n=8 mice per group).  ***P=0.001, **P=0.01, *P=0.05 (1 
way ANOVA).   
 
Accordingly, increased amounts of IL-17 and IFNin the lung and TNF-in the BAL 
were found in HDM allergic mice previously infected with M. catarrhalis (Fig 10 A,B). 
Serum levels of HDM-specific IgG2c antibodies were also increased in the M.catarrhalis 
infection during HDM challenge as compared to the uninfected allergic HDM group Fig 
10. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Cytokine measurement of BAL and lung   (A) TNF in  BALF.(B)IFN and IL-17 in 
lung homogenates.(C)Measurement of the total amounts of IgG1, IgG2c titers in the serum at day 
23. Data were from two independent experiments (n=6 mice per group).  ***P=0.001, **P=0.01, 
*P=0.05 (1 way ANOVA).   
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5.6 M.CATARRHALIS INFECTION EXACERBATES AN ESTABLISHED 
HDM-INDUCED AIRWAY RESPONSES 
 
We next wondered whether changing the time point of M.catarrhalis infection would lead 
to similar effect on allergic HDM asthma. Accordingly, we first infected mice 1 day after 
the final HDM challenge and analysed the BAL one week later to address the effect of the 
adaptive immune response (Fig.11 A). Inflammatory cell infiltration was increased in the 
airways of mice infected after HDM challenge (Fig.11 B). This inflammation was 
dominated by enhanced neutrophilic, and lymphocytic infiltrates (Fig.11 C).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. M.catarrhalis infection exacerbates an established HDM-induced airway responses  
(A) Animals were treated with HDM or PBS on days 0, 7, 14 and 21, analyses refer to day 29. 
When the mice were killed and samples were taken. (B,C) Bronchoalveolar lavage fluid (BAL) 
analysis in wt mice for cell infiltrates. . Data were from two independent experiments (n=8 mice 
per group).  ***P=0.001, **P=0.01, *P=0.05 (1 way ANOVA).   
 RESULTS 50 
 
Furthermore Lung slices were stained for mucus production by PAS staining and goblet 
cells. As seen by PAS staining, PBS control mice had healthy lungs whereas the HDM 
allergic mice showed mucus-producing goblet cells within the lung epithelium However, 
M.catarrhalis infection after HDM exposure showed significantly increased airway 
inflammation, goblet cell hyperplasia and mucus production from the lung compared to 
HDM allergic group (Fig.12 A, B, and C). 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. M.catarrhalis infection exacerbates an established HDM-induced airway responses  
Animals were treated with HDM or PBS on days 0, 7, 14 and 21, analyses refer to day 29. When 
the mice were killed and samples were taken. (A, B) Histological quantification of goblet cell 
counts, (C) infiltration of cell into lung tissue, inflammation score. . Data were from two 
independent experiments (n=8 mice per group).  ***P=0.001, **P=0.01, *P=0.05 (1 way 
ANOVA).   
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In order to determine the cytokine profile of T cells, we directly restimulated lung cells for 
4 hours with PMA and ionomycin in the presence of brefeldin A and stained immediately 
for CD4 and IL-17, IFN, IL-5 and IL-13 to determine the percentage of Th17, Th1, Th2 
cells. In line with increased lymphocytic infiltrations, the frequencies of Th1, Th17 and 
Th2 were enhanced in lung tissue from mice infected after HDM challenge compared to 
the uninfected allergic HDM group (Fig.12 A).  
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Figure 12.  T cell profile from infection after an established HDM allergic airway response 
(A) Live lung cell from PBS, HDM and HDM with M.catarrhalis instilled mice were analysed for 
the frequency of IL-17A, IFN, IL-5 and IL-13 T cells (n= 8 mice per group). Statistical 
significance was determined with 1-way (ANOVA) *P=0.05, **P=0.01 
 
 
5.7 M.CATARRHALIS INFECTION PRIOR TO HDM SENSITISATION 
EXACERBATES ASTHMA VIA T-CELL IMMUNE RESPONSE  
 
Further, we analysed whether a previous infection with M. catarrhalis that has already 
been resolved is still able to exacerbate HDM allergic reactions. Therefore, mice were 
infected with M.catarrhalis 7 days before first HDM exposure and analysed on day 23 
(Fig.13 A). The results show that infiltrations with inflammatory cells were increased in 
the airways of mice infected after HDM challenge (Fig.13 B). Interestingly, under these 
conditions, inflammation was dominated by enhanced lymphocytic infiltrates (Fig.13 C) 
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Figure 13. M.catarrhalis infection prior to HDM exposure exacerbates allergic airway disease 
via lymphocyte recruitment  Protocol for HDM-induced allergic airway inflammation. WT mice 
were given four intranasal (i.n) challenges with HDM extract, once per week. M.catarrhalis was 
given 7 days before the first HDM exposure intranasal. (B)Total BALF cell counts. (C) Differential 
cell counts. . Data were from two independent experiments (n=8 mice per group).  ***P=0.001, 
**P=0.01, *P=0.05 (1 way ANOVA).   
 
In contrast to the PBS - and HDM control groups, infection prior to HDM exposure 
induced Foxp3
+
 CD25
+
 regulatory T cells (Treg) in the lungs. Despite enhanced Treg 
frequencies, the amount of pulmonary Th17, IFN- and IL-5-secreting was still enhanced 
by a factor of two in the lung (Fig.14 D). Collectively these data suggest that exacerbation 
of HDM-allergic reactions is independent of the time point of infection and that IL-17 has 
a pathogenic role in asthma, enhancing the severity of HDM-induced allergic response. 
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Figure 14. M.catarrhalis infection prior to HDM exposure exacerbates allergic airway disease 
via T-cell activation  
Protocol for HDM-induced allergic airway inflammation. WT mice were given four intranasal (i.n) 
challenges with HDM extract, once per week. M.catarrhalis was given 7 days before the first HDM 
exposure intranasal. (A) Live lung cell from PBS, HDM and HDM with M.catarrhalis installed 
mice were analysed for the frequency of IL-17A, IFN, IL-5, IL-13, FoxP3 and CD25 T cells. 
Populations are sequentially gated on total live cells (n=12 mice per group).  
 
5.8 IL-17 IS A KEY CYTOKINE IN DEVELOPMENT OF HDM-
ALLERGIC AIRWAY INFLAMMATION 
 
As IL-17 has been reported to be associated with the severity and pathogenesis of infection 
induced asthma (Bisgaard et al. 2014), we determined whether IL-17 enhances severity of 
allergen-driven AAD in the absence of bacterial infection. We employed IL-17 deficient 
mice to assess the role of this cytokine during development of HDM allergic airway 
responses. (Fig.15 A). In contrast to wt animals, IL-17 KO mice revealed significantly less 
inflammatory cell infiltration to the airways during HDM exposure (Fig.15 B). The 
inflammation was dominated by significantly less neutrophils, eosinophils and 
Lymphocytes in BAL fluid (Fig.15 C).  
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Figure 15.  Reduced HDM-allergic airway inflammation in the absence of IL17  
(A) Protocol for HDM-induced allergic airway inflammation. WT and IL-17AF -/- mice were 
given four intranasal (i.n) challenges with HDM extract, once per week. (B)Total BALF cell 
counts. (C) Differential cell counts. Neutrophils, Eosinophils and Lymphocytes. (n= 8 mice 
per group). Statistical significance was determined with 1-way (ANOVA) *P=0.05, 
**P=0.01, ***P=0.001 
 
The predominant sign of allergic asthma is the lung inflammation accompanied with 
excessive mucus production. Therefore, histological analysis of the whole lung was the 
most important readout. Lung slices were stained for mucus production by PAS staining 
and the goblet cells were microscopically quantified in relation to the airway surface using 
the CellF software. The amount of goblet cells is a direct hint of disease severity in the 
lung. The graph (fig16. A) displays reduced goblet cell numbers per mm of the airways in 
IL-17 KO mice as compared to the wt mice. PAS staining could also quantify the 
inflammation score which displays the infiltration of cells to the lung tissue. The data show 
an increase in airway infiltration of cells in an HDM dependent manner, which was 
significantly reduced in IL-17AF
-/-
 animals (Fig.16 B, C ). However, the number of Th1, 
Th2 cells and HDM specific IgG1 titers were not decreased in IL-17AF
-/-
 mice compared 
to wt animals (Fig.16 D, E ).  
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Collectively, these data show that lack of IL-17 markedly reduced the severity of allergic 
asthma responses, demonstrating that this inflammatory cytokine significantly contributes 
to the full asthma phenotype in the HDM model.       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. Reduced HDM-allergic airway inflammation in the absence of IL17  
 (A)Periodic acid Schiff (PAS) - stained for mucus producing goblet cells in PBS or HDM treated 
wildtype (WT) and IL-17AF-/- mice. (B) Histological quantification of goblet cell counts, (C) 
infiltration of cell to lung tissue, inflammation score. (D) Live lung cell from PBS, HDM installed 
mice were analysed for the frequency of IFN, IL-5 and IL-13 T cells. Populations are sequentially 
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gated on total live cells (n=12 mice per group). (E) Measurement of the total amounts of IgG1, 
IgG2c titers in the serum. 
 
5.9 REDUCED INFLAMMATORY RESPONSE TO M.CATARRHALIS 
INFECTION IN IL-17 KO MICE  
 
Neutrophil influx into infected tissues is a first-line defence mechanism predominantly 
controlled by IL-17. We wondered, whether IL-17 KO mice are able to control microbial 
airway infection and compared antibacterial resistance in wt and IL-17KO mice. Despite 
comparable amounts of M. catarrhalis two hours after infection, IL-17 KO mice cleared 
bacteria surprisingly more rapidly from lungs as compared to wt animals (Fig.17 A). Total 
cell counts were significantly reduced after 4 days of M.catarrhalis infection in the IL-
17AF KO compared to WT mice. This reduction was mainly dominated by the reduction 
of neutrophils, and miner reduction of eosinophils, lymphocytes and macrophages (Fig.17 
B, C) 
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Figure 17. M.catarrhalis infection in WT and IL-17 KO mice 
 
IL-17 KO (black bars) and wt mice (white bars) were infected (i.n.) with M.catarrhalis. BAL and 
lung were harvested at indicated time points. (A) Bacterial recovery from lung homogenates (B) 
airway inflammation represented by BALF total cell counts (C) Differential cell counts. . Data 
were from two independent experiments (n=8 mice per group).  ***P=0.001, **P=0.01, *P=0.05 
(1 way ANOVA).   
 
To determine the cause of faster clearance in IL-17AF KO mice we wondered whether 
early neutrophil influx is altered in IL-17AF KO mice after M.catarrhalis infection  
However, cell counts in the BAL-fluid and lung tissue revealed 24h after infection 
comparable number of neutrophils in wt and IL-17 KO mice (Fig.17 A), Similar or 
enhanced levels of the CXCL1, 5 and 10 chemokines in IL-17 KO mice seems to 
compensate for early neutrophil attraction independently of IL-17 (Fig.17 B).            
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Figure 18. Neutrophils influx induced by M.catarrhalis infection in early phase is independent 
of IL-17AF 
(A)Lung cells measured by FACS for neutrophil cell which are Ly6C
+and Ly6G+positive and 
Macrophages which are Ly6C
+
Positive at day 1 after M.catarrhalis infection (B) BALF levels of 
CXCL1, CXCL5 and CXCL10 were assessed by using CBA assay. . Data were from two 
independent experiments (n=8 mice per group).  ***P=0.001, **P=0.01, *P=0.05 (1 way 
ANOVA).  
  
Furthermore, for examination of pathophysiological changes of the lung induced by 
allergic asthma, the lung sections were first stained with haematoxylin and eosin. The 
amount of infiltration cells is a direct hint of disease severity. The graph (fig.19 A) shows 
the number of infiltrating cells around the vessels of the airways in M.catarrhalis infected 
mice , which was significantly reduced in IL-17AF
-/-
 mice compared to the WT mice in 
different time points. 
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Figure 19. Histological analysis of the lung tissues after M.catarrhalis infection   
(A)  Hematoxilin and eosin stained for infiltration of cells and pathophysiological changes and 
lung damage in PBS or M.catarrhalis in different time points in WT and IL-17AF
-/-
 mice. (B) 
Inflammation Score. . Data were from two independent experiments (n=8 mice per group).  
***P=0.001, **P=0.01, *P=0.05 (1 way ANOVA).   
       
5.10 IL-17AF DEFICIENCY RESULTS IN REDUCED MORBIDITY AND 
MORTALITY OF M.CATARRHALIS INFECTION 
 
As M. catarrhalis has been shown to induce a strong inflammatory immune response via 
activation of the epidermal growth factor receptor (Slevogt H et al. 2014), the amount of 
inflammatory cytokines was analyzed in serum and BAL. M. catarrhalis infection induced 
on day one significantly more IL-6 and TNF in serum and IL-6, TNFand IL-1ß were 
significantly induced in BAL WT animals compared uninfected mice. These inflammatory 
cytokines were massively reduced in infected IL-17 KO mice (Fig.20 B). To address 
whether this dramatic increase in proinflammatory cytokine production has any 
consequences on survival, we analyzed the responses to M.catarrhalis in mice of WT and 
IL-17AF KO mice. Despite the same infection dose (2×10
8
 CFU), WT mice (days 1 till 7 
after infection) died within 24-48 h, whereas all IL-17 KO mice survived (Fig.20 C). 
Thus, these findings suggest that IL-17AF plays a role in the enhancement of morbidity 
and mortality of M.catarrhalis infection.  
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Figure 20.Reduced local and systemic pro-inflammatory cytokines in IL-17AF
-/-
 mice  
upon M. catarrhalis  infection  
WT and IL-17AF-/- mice were infected with 2×10
8 
CFU of M.catarrhalis infection (A,B) 
Proinflammatory cytokines were analysed by CBA flex assay for Pro-inflammatory IL-6, TNF-a 
and IL-1ß cytokines at different time points in BAL and Serum. (C) Survival curve.  . Data were 
from two independent experiments (n=8 mice per group).  ***P=0.001, **P=0.01, *P=0.05 (1 
way ANOVA).   
 
To determine whether Tregs and IFN were involved in the suppression or enhancement of 
airway inflammation, we quantified Tregs after infection in both Wt and IL-17KO mice. 
We observed that IL-17KO mice infected with M.catarrhalis increased the numbers of 
Tregs, and IFN similarly to infected WT mice (Fig.21 A, B, C, D).  Taken together, 
M.catarrhalis infection does not affect Treg cells nor Th1 cells in the absence of IL-17. 
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Figure 21.  Analysis of CD25+, FoxP3+ T cells and IFNin the lung of WT and IL-17AF KO 
mice after M.catarrhalis infection  
Treg numbers in the lung, IFN numbers in the BAL and lung at indicated time points  (A)Tregs 
cells were analysed after 7 days of M.catarrhalis infection in Wt and IL-17AF
-/-
 mice. (B) 
IFNmeasurement in the BAL (C) mRNA expression in lung tissue for IFN was assessed (D) 
frequency of IFN+ CD4+ T cells was analysed by flow cytometry.  
 
5.11 M.CATARRHALIS EXACERBATION OF HDM-INDUCED 
ALLERGIC INFLAMMATION IS DEPENDENT ON IL-17 
 
To further investigate whether IL-17 is also crucial for infection induced exacerbation of 
allergic airway disease (AAD), IL-17 KO mice were infected during HDM allergen 
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exposure and analyzed, as shown in (Fig.22 A). The data demonstrate that both total 
cellularity and the numbers of neutrophils, eosinophils and lymphocytes as well as CXCL1 
expression in the BAL of infected IL-17 KO mice were comparable to the non-infected, 
HDM control group (Fig.22 B, C).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                          
 
 
 
 
 
 
Figure 22. M. catarrhalis induced exacerbation of  AAI is mediated by IL-17 
C57Bl/6 animals were intranasally infected with 2x10
8
 CFU M. catarrhalis after second HDM 
exposure. BAL and lungs were analyzed at day 23. (A) Protocol (B) Total cell counts in BALF. (C) 
Differential cell counts. (D) The secretion of CXCL1 chemokine in the BAL. 
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Furthermore, Lung slices were stained for mucus production by PAS staining and goblet 
cells. As visualized by PAS staining, PBS control mice had healthy lungs whereas the 
HDM allergic mice showed mucus-producing goblet cells within the lung epithelium of IL-
17AF
-/-
 mice. However, M.catarrhalis infection during HDM exposure showed no further 
increase of airway inflammation, goblet cell hyperplasia and mucus production from the 
lung compared to HDM allergic IL-17AF KO group (Fig.23, A, B). 
Thus, similar numbers of mucus secreting cells and inflammation score suggests that IL-17 
is a key cytokine for infection induced exacerbation of AAD (Fig.23 C).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23. Histological lung analysis of M.catarrhalis infection during HDM induced AAD in 
IL-17AF
-/-
 
Animals were treated with HDM or PBS on days 0, 7, 14 and 21, analyses refer to day23. When the 
mice were killed and samples were taken. (A) Representative PAS- stained airways. (B) Goblet cell 
counts in lung tissues. (C) Inflammation Score. . Data were from two independent experiments 
(n=8 mice per group).  ***P=0.001, **P=0.01, *P=0.05 (1 way ANOVA).   
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However, it has to be mentioned that infection of HDM allergic IL-17 KO mice still 
enhanced the expression of pulmonary IFN as well as IL-5 and IL-13 but not TNF-in 
the BAL (Fig 24 A, B). The absence of IL-17 did not completely abrogate HDM asthma, 
which suggested that other factors such as Th2 and Th1 drove the remaining allergic 
response (Fig.24 C, D). Serum levels of HDM-specific IgG1 and IgG2c antibodies were 
also not differed in the M.catarrhlis infection during HDM challenge as compared to the 
uninfected allergic HDM group (Fig.24 E). 
Together, these findings show that IL17 similarly contributes to exacerbation of HDM-
induced allergic responses by M. catarrhalis infection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24. IL-17AF
-/-
 mice are protected from M.catarrhalis induced asthma exacerbation  
C57Bl/6 animals were intranasally infected with 2x10
8
 CFU M. catarrhalis after second HDM 
exposure. BAL and lungs were analyzed at day 23. (A) TNF- in BALF (B) IFN, IL-5 and IL-13 in 
lung homogenates (C)Intracellular staining of CD4
+
 lung T cells producing IFN, IL-5 and IL-13. 
(D) Measurement of the total amounts of IgG1, IgG2c titers in the serum.Data were from two 
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independent experiments (n=16 mice per group).  ***P=0.001, **P=0.01, *P=0.05 (1 way 
ANOVA).   
 
5.12 ANTI TNF-TREATMENT ATTENUATES IL-17 DEPENDENT 
EXACERBATION OF INFECTION INDUCED AHR 
 
Increased amounts of pulmonary TNF-is found in children infected with pathogenic 
airway bacteria or patients suffering from severe, refractory asthma. Further, it known that 
TNF- and IL-17 act synergistically in inflammation triggered recruitment of neutrophils 
(Griffin G, 2012 J.I.) We thus wondered whether TNF- neutralization attenuates the 
inflammatory phenotype of infection induced exacerbation of allergic airway reactions. 
Briefly, HDM sensitized mice were treated with anti-TNF-mAbsµg i.p.) four hours 
before intranasal infection with M. catarrhalis and analyzed at day 23 as depicted in Fig.25 
A. Control groups included mice that received PBS or HDM alone as well as infected, 
HDM sensitized animals.  
Differential cell counts of BAL cells revealed that predominantly neutrophils were reduced 
by anti-TNF- treatment while the numbers of macrophages were increased when 
compared to HDM/infected controls. Increase of BAL macrophages after TNF- 
neutralization seems to compensate for the low number of neutrophils for elimination of M. 
catarrhalis. No significant reduction after TNF- treatment was seen in the number of 
eosinophils or lymphocytes (Fig.25 B, C).  
.      
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Figure 25. M.catarrhalis during HDM exposure augments allergic airway responses via TNF  
C57Bl/6 animals were i.n infected with 2x10
8
 CFU M. catarrhalis after second HDM exposure. 
Administration of a rat anti murine TNF (100µg; MP6-XT22) or an IgG1 control antibody i.p 
intraperitoneal before 4 hours of M.catarrhalis infection. BAL and lungs were analyzed at day 23. 
(A)Protocol (B) Total cell counts in BALF. (C) Differential cell counts. . Data were from two 
independent experiments (n=6 mice per group).  ***P=0.001, **P=0.01, *P=0.05 (1 way 
ANOVA).   
 
Analysis of the lung tissue confirmed that anti-TNF- treatment vastly neutralized 
infection induced inflammatory infiltrates of HDM allergic animals which was also 
reflected by the reduced number of PAS
+
 cells and low inflammation score (Fig.26 A,B,C). 
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Figure 26. M.catarrhalis during HDM exposure augments allergic airway responses via TNF  
C57Bl/6 animals were i.n infected with 2x10
8
 CFU M. catarrhalis after second HDM exposure. 
Administration of a rat anti murine TNF (100µg; MP6-XT22) or an IgG1 control antibody i.p 
intraperitoneal before 4 hours of M.catarrhalis infection. BAL and lungs were analyzed at day 23. 
(A) Representative periodic acid Schiff- stained airways. (B) Goblet cell counts in lung tissues. (C) 
Inflammation score. . Data were from two independent experiments (n=6 mice per group).  
***P=0.001, **P=0.01, *P=0.05 (1 way ANOVA).   
 
 
We next wondered whether TNF- neutralization also affects pulmonary T cell activation. 
Analysis of lung Th1, Th2 and Th17 cytokine secreting CD4
+ 
T cells revealed that anti-
TNF- treatment slightly attenuated the activation of IFN- and IL17+ lymphocytes but 
had no influence on the low frequency of IL5/IL13 secreting T cells (Fig. 27 A,B ). 
Together with the unaltered ratio of IgG1 and IgG2c antibody titers, the data show anti-
TNF- treatment does not affect the Th1/Th2 balance. 
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In summary, the experiments revealed that one application of anti-TNF-mbs is 
sufficient to hugely attenuate M. catarrhalis induced exacerbation of AHR 
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Figure 27. M.catarrhalis during HDM exposure augments allergic airway responses via TNF 
(A) staining of CD4
+
 lung T cells producing IL17A, IFN, IL-5 and IL-13.(B) Measurement of the 
total amounts of IgG1, IgG2c titers in the serum. Data were from two independent experiments 
(n=16 mice per group).  ***P=0.001, **P=0.01, *P=0.05 (1 way ANOVA). 
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6. DISCUSSION. 
 
Asthma is a complex syndrome with many clinical phenotypes and caused by a combination 
of complex and incompletely understood environmental and genetic interactions (Martinez et 
al. 2007). It has been recently shown that increased rates of asthma are due to changing 
epigenetics and changing living environment (Dietert RR et al. 2011). Many environmental 
factors have been associated with asthma development and exacerbation including allergens, 
air pollution, dust mites cockroaches and infections. Certain viral and bacterial respiratory 
infections, such as rhinovirus, Haumophilus infuenzae and Moraxella catarrhalis have been 
shown to increase the risk of the development of asthma and asthma exacerbation (Murray et 
al. 2010) (Bisgaard et al. 2007), while other microbial infections, such as Acinetobacter 
lowffii, seem to be associated with a reduced  risk of asthma development (Debarry J et al. 
2007). 
 These findings demonstrate that we are still lacking a deep understanding of the mechanisms 
that determine asthma protection versus induction or exacerbation by pathogens. It has been 
shown that M.catarrhalis is a common pathogen that causes middle ear infections and 
exacerbations of chronic obstructive pulmonary disease in infants and children and lower 
respiratory tract in adults in the USA (Murphy et al. 1998) (Herva E et al. 2001). However, 
compared to H.influenzae and S.pneumoniae, the knowledge about M.catarrhalis induced 
host immune response is lacking. Thus, we were interested to investigate the pulmonary 
immune response after M.catarrhalis infection and the nature of the association between 
M.catarrhalis infection and allergic airway inflammation. 
 
6.1 PULMONARY INNATE IMMUNE RESPONSE IN M.CATARRHALIS 
INFECTION   
In this study we have established and characterized for the first time a murine model of 
M.catarrhalis infection with a strain isolated from humans. Since M.catarrhalis strain was 
isolated from human patients, we were wondering if it is able to colonize mice after intranasal 
instillation. Infection of C57Bl/6 mice revealed that bacterial titers of the lung were maximal 
at day 2 and then declined rapidly resulting in clearance by day 6 in WT mice. 
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In contrast, the previously described murine infection with H. influenzae, which is also 
associated with asthma exacerbation, revealed the course of infection is quite different to that 
of M. catarrhalis. Here bacterial numbers peaked at day 5 and clearance of the pathogen was 
observed by day 16 after infection (Ama-Tawiah Essilfie. et al. 2011). Moreover, bacterial 
clearance was mediated by early but surprisingly low amount of neutrophils in the airways.  
Compared to H. influenzae, M. catarrhalis infection induced with delayed kinetics high 
amounts of neutrophils which seem to be responsible for the fast clearance of this pathogen.   
Accordingly, high amounts of chemokine attracting neutrophils in the BAL coincide with the 
prompt appearance of neutrophils and may act as a feedback loop to further attract neutrophils 
and T cells. 
 
While TNF stands as one of the most impactful cytokines in defence against a wide range of 
infections, it also plays a central role in the pathogenesis of an array of inflammatory diseases. 
Indeed, TNF blockade represents one of the most effective treatments for autoimmune 
diseases, such as rheumatoid arthritis, while increasing the risk of some infectious diseases. 
Despite the investigation for over four decades, the mechanism by which TNF provides 
resistance against infection remain unclear and has been attributed to many affects, such as 
enhancing the expression of cytokines, chemokines, inflammatory cell trafficking and 
activating phagocyte oxidase (Sedgwick et al, 2000; Strieter et al. 2002). Although previous 
studies has demonstrated that TNF- deficient mice are more susceptible to infections such as 
K.pneumoniae (Laichalk et al. 1996), it is still unclear what effector functions and TNF 
producing cells are induced.  
 
A recent study has shown that M.catarrhalis induced activation of mitogen activated protein 
kinase (MAPK) is essential for the secretion of pro.inflammatory cytokine TNF- (Ferdaus 
Hassan, Xin-Xing Gu et al. 2012). DeVries has also shown that TNF- is upregulated after 
M.catarrhalis infection by human epithelial cells (DeVries et. el 2004 ).Similarly, our study 
confirmed that M.catarrhalis induces TNF- after 24 hours of infection. To determine the 
source of TNF- which could be produced by several cells such as monocytes, dendritic cells, 
B cells, CD4
+
 T cells, neutrophils, mast cells and eosinophils, and stromal cells, ie, 
fibroblasts, epithelial cells, and smooth muscle cells. We found that TNF- is produced by 
tracheal epithelial cells which are the cells that meet the infection for the first time and start an 
immune reaction against M.catarrhalis. These cells were isolated from WT animals infected 
with M.catarrhalis and analysed at 4 and 24 hours after infection.  
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 One of the most striking discovery was that TNF is the mediator of endotoxin poisoning and 
thus plays an important role in septic shock. So we wondered whether TNF- is the mediator 
of pulmonary inflammation and thus responsible for the lethality often seen after 
M.catarrhalis infection. Our study showed that TNF- enhances IL-6, IL-17 and IL-1ß 
cytokines which are known to play an important role in many respiratory infections as pro or 
anti-inflammatory cytokines. Since M.catarrhalis infection resulted in enhanced mortality at 
the peak time point of these cytokines suggesting their involvement in infection induced 
pathology. We found that neutralization of TNF- resulted in local and systemic reduction of 
IL-6, IL-1ß and IL-17 with subsequent protection and survival in M.catarrhalis infected mice.  
 Collectively, in some acute infection cases, monoclonal anti-TNF antibodies could have a 
high therapeutic value (K.Thavarajah et al. 2009).  
Next, to characterize the involvement of IL-6.  Since IL-6 is one of the cytokines that were 
induced after M.catarrhalis infection together with the proinflammatory cytokines TNF-and 
IL-1ß. We wondered whether the contribution of IL-6 during M.catarrhalis infection was 
similar to TNF-.  IL-6 is known to play an important role in the induction of acute phase 
reactions. Recent studies suggested that IL-6 plays an anti-inflammatory role during Y. 
enterocolitica and S.pneumoniae infection (Dube PH et al. 2004) (Albrecht LJ et al. 2016). 
Another study has shown that IL-6 plays a pro-inflammatory role during enteroviral infections 
(Khong WX et al. 2011). However, whether it plays a pro- or anti-inflammatory role in local 
or systemic responses after M.catarrhalis infection remains unclear. In order to address this, 
we neutralized IL-6 by injection of antibodies and observed increased local and systemic 
TNF- as well as early IL-1ß and IL-17 in the BAL. Most surprisingly, anti-IL-6 treatment 
resulted in enhanced mortality demonstrating that IL-6 exerts an anti-inflammatory function 
during pulmonary M.catarrhalis infection by controlling the level of proinflammatory 
cytokines.  
 
 
6.2 PULMONARY TH17 IMMUNE RESPONSE TO M.CATARRHALIS 
INFECTION  
 
IL-17 is an important mediator of neutrophilic inflammation during infection and in disease 
states (Gibson PG et al. 2001) (Simpson JL et al. 2007). IL-17 is produced by several cells 
including Th17 cells (Hellings PW et al. 2003),  T cells ( Lockhart E et al. 2006), 
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macrophages (Song C et al. 2008) and neutrophils (Ferretti et al. 2003) and has critical roles 
in host defence against bacterial infections( Ye P et al. 2001), suggesting a potential role in 
the pathogenesis of bacterial-induced neutrophilic asthma.  
The importance of IL-17 in mediating protection against pulmonary bacterial infection was 
shown for several pathogens, including Klebsiella pneumoniae, Mycoplasma pneumoniae, 
Bordatella pertussis and M.tuberculosis after vaccination with BCG (Baraldo et al. 2007). 
Consequently, IL-17 receptor KO mice revealed an increased susceptibility for bacterial 
infections, due to decreased neutrophil and macrophage recruitment to the site of bacterial 
entry (Barnes 2008). But at the same time, IL-17 released into the airways recruits neutrophils 
and thus promotes neutrophilic asthma which is characterized by treatment resistance 
compared to other phenotypes (Larsen et al. 2014; Fahy 2009; Brightling et al. 2008). Most 
importantly,  expression of pro-inflammatory IL-17 in the airways of asthmatics has been 
shown to correlate with disease severity (N'Guessan et al. 2014).  
 
Since IL-17 has been described as key cytokine involved in the pathogenesis of H.influenzae 
infection triggered neutrophilic inflammation in allergic airway disease. Therefore we tested    
the amount, frequency and the origin of IL-17 production after M.catarrhalis infection. We 
could show that the majority of IL-17 secreting cells in the lung were conventional CD4
+
 T 
cells which started to produce IL-17 at day 7 post infection in BAL and lung. However the 
role of IL-17 producing cells in M.catarrhalis infection was unknown. To investigate the 
contribution of IL-17AF after M.catarrhalis infection we used IL-17AF
-/-
 mice versus wt. 
Despite comparable amounts of M. catarrhalis titers two hours after infection , IL-17AF KO 
mice cleared bacteria surprisingly more rapidly from the lung as wt animals. Cell counts in 
the BAL-fluid and lung tissue shortly after infection revealed comparable number of 
neutrophils in wt and IL-17 KO mice. This might be explained by similar or enhanced levels 
of the chemoattractant CXCL1, CXCL5 and CXCL10 in IL-17AF KO mice which might 
compensate for early neutrophil attraction independent of IL-17.  However, later stages of 
infection, the amount of neutrophils was significantly lower in IL-17AF deficient mice, most 
likely other compensatory mechanisms which were not addressed in our work might be 
active. On the other hand, lack of IL-17 might well explain the reduced pathology which is 
seen in lung sections of M. catarrhalis infected  IL-17AF
-/-
. In accordance with our findings, a 
similar study has shown that infection of IL-17
-/- 
mice with K. menoumonia did not reduce the 
recruitment of neutrophils into  infected lungs (Xiong H et al. 2016). Thus, it remains 
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enigmatic why IL-17AF KO mice clear the infection faster and recruit similar amounts of 
early neutrophils after M.catarrhalis infection. 
 
 
6.3 T CELLS IN M.CATARRHALIS INFECTION 
 
Several studies have proposed that different kinds of infection such as Streptococcus 
pneumoniae, can promote the differentiation of Treg cells (Preston J.A 2010). Tregs are an 
important cell involved in immune tolerance and the suppression of inflammation. We 
wondered whether the protection affect in IL-17AF
-/-
 infected mice was due to enhanced 
Tregs.  M.catarrhalis infection induced CD25
+ 
FoxP3
+
 CD4
+
 T cells with similar frequencies 
in wt and IL-17AF
-/-
 mice. Although the regulatory function of Tregs have not been analyzed 
in detail, our findings suggest that M.catarrhalis induced Treg cells have a limited ability to 
control Th1 and Th17 responses. However, to make a final conclusion about the involvement 
of Tregs in infection triggered asthma responses, experiments with Treg deficient mice have 
to be performed.  
Another important cytokine for antibacterial defence is IFN which is produced primarily by 
T cells and NK cells.It has been shown that IFNplays an important role in mediating 
macrophage activation in controlling a number of intracellular pathogens, including 
leishmanial major (Liew, F.Y et al. 1990), listeria monocytogenes (KIderlen, A.F, S.H. 
Kaufmann et al. 1984). IFN enhances the microbicidal function of macrophages by 
stimulating the synthesis of reactive oxygen intermediates and nitric oxide (Stark GR, IM 
Kerr et al. 1998). 
 So we wondered whether IFN plays a role in M.catarrhalis infection. In our study IFN was 
strongly induced after M.catarrhalis infection in wt, therefore we suggested if the protection 
of IL-17AF
-/-
 mice was due to increased amounts of IFN that may compensate for the lack of 
IL-17. However, our results clearly revealed that WT and IL-17AF
-/-
 mice produced similar 
amounts of IFN suggesting that IFN does not account for enhanced antibacterial protection 
of IL-17AF
-/-
 mice.  
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6.4 M.CATARRHALIS INFECTION EXACERBATES ALLERGIC AIRWAY 
INFLAMMATION  
 
M. catarrhalis has been shown to be an important risk factor for newborns to either develop 
asthma in later years or for adults with chronic pulmonary diseases to exacerbate disease 
symptoms (Jackson et al. 2011; Pelaia et al. 2006). While there is evidence that the frequency 
of respiratory infections rather than infection with a specific pathogen influences asthma 
development, it is currently still not known whether the time of pulmonary infections affects 
asthma, i.e. what is the influence of infection before, during and after contact with allergen 
(Bisgaard et al. 2007a). Therefore, we studied the immunological mechanisms of infection 
triggered asthma exacerbation at various time points and tested potential targets for their 
therapeutic efficiency. Since murine models of AAD have helped to reveal some of the 
potential mechanisms and thus play an important role in identifying the contribution of 
distinct immune reactions in development of allergen- induced inflammation and airway 
hyperresponsiveness. Today, several experimental models of asthma exist, with OVA and 
HDM model as the most prominent ones. While the OVA model of allergic inflammation 
shows several limitations with respect to the human disease (Taube C, et al. 2004), we used 
the House Dust Mite (HDM) model which is clinically more relevant to humans, as  HDM is 
a common allergen associated with asthma. The model of HDM induced AAD is a mixed 
Th1/Th2 inflammatory phenotype with increased numbers of eosinophils and neutrophils. As 
we were interested to study the effect of asthma exacerbation by M.catarrhalis with special 
interest whether the time-point of infection with M. catarrhalis influences the outcome of 
asthma exacerbation. Infection during HDM allergen exposure massively increased the influx 
of neutrophils and eosinophils while infection after complete HDM sensitization caused 
asthma exacerbation primarily by neutrophils. In contrast, infection prior to HDM exposure 
predominantly triggered the expansion of pulmonary T lymphocyte populations. However, 
common to all three settings of infection is the induction a mixed pulmonary Th1, Th2, and 
Th17 immune response. Thus, our data suggest that bacterial infection irrespective of the 
time-point of allergen exposure influences the development or outcome of allergic airway 
reactions and reflects the situation in patients: Viral and/or bacterial infections in early life or 
during asthma have been associated with the development or exacerbation of asthma, 
respectively (Bisgaard et al. 2007b; Lambrecht und Hammad 2015; Vock et al. 2010b). Our 
experimental data show, that a non-persisting infection of the respiratory tract with 
M.catarrhalis has the potential to exacerbate lung allergic inflammatory responses, 
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independently of the time, i.e. before, during or after allergen contact. Infection-triggered 
exacerbation of HDM-allergic reactions was due to the enhanced influx of neutrophils, 
eosinophils and Th1, Th2, and Th17 cells together with enhanced secretion of inflammatory 
IL-17, TNF-, IFN- and the Th2 cytokines IL-5 and IL-13.  
 
However these murine experimental findings have to be set in the context of the human 
situation. Hans Bisgaard has demonstrated that the association between M.catarrhalis, 
H.influenzae and S.pneumoniae and acute severe exacerbation of wheeze was time specific. 
This would show that our findings are not of clinical relevance. Bisgaard has shown that 
newborns infected with M.catarrhalis are more prone to asthma at later life and patients with 
established asthma will develop exacerbation of the disease.  
Probably most interesting is the fact what happens if we were infected with M.catarrhalis a 
long time before allergic sensitization. Under such conditions, the effect of pathogen-specific 
memory T cells on asthma development or exacerbation can be tested. With respect to our 
experimental setup, this might have been too early.  
.  
 
6.5 IL-6 AND TH1 IN ASTHMA  
 
IL-6 has been considered as promising target to reduce pathogenesis of asthma and COPD, 
particularly those of eosinophilic/neutrophilic phenotype (Bonnelykke et al. 2015; Green et al. 
2002). On the other hand, IL-6 is known to mediate pro-inflammatory and anti-inflammatory 
immune functions, which are mediated via trans- and classical signaling, respectively 
(Folsgaard et al. 2013). Our data however show, that anti-IL6 treated, non-allergic animals 
were highly susceptible to M. catarrhalis infection with high amounts of local and systemic 
TNF-that we did not further consider IL-6 as appropriate target for treatment of M. 
catarrhalis triggered asthma exacerbation.  
 
 The typical Th1 cytokine IFN has been shown to play an important role in the development 
of AHR and in aggravating inflammatory events in asthma. Moreover, studies could not show 
airway hyperresponsiveness after adoptive transfer of OVA specific Th1 cells, other groups 
were able to induce AHR (J.Cui, SPazdziorko et al. 2005). However, Th1and Th2 responses 
may even act in combination to augment each other’s activity to induce airway inflammation 
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and AHR (J.G.Ford et al. 2001).Nevertheless, more studies are required to fully elucidate the 
role of Th1 cells and especially of IFN in asthma pathology. (Christina Vock et al. 2010). 
Since M.catarrhalis infection induced significantly Th1 cells during allergic airway disease. 
Therefore we were interested to investigate the effect of Th1 cell in our model. Since IL-
17AF
-/-
 mice were protected against M.catarrhalis induced AAD we wondered whether the 
protection affect in IL-17AF
-/-
 infected mice was due to altered Th1 cells .  M.catarrhalis 
infection induced IFN+ CD4+ T cells with similar frequencies in wt and IL-17AF-/- mice. 
Although the function of Th1 cells have not been analyzed in detail, our findings suggest that 
M.catarrhalis induced Th1 cells have a limited ability to control Th2 and Th17 responses. 
However, to make a final conclusion about the involvement of Th1 in infection triggered 
asthma responses, experiments with Th1 deficient mice have to be performed. Whether these 
cells play a role in this protection.  
 
 
 
6.6 IL-17 IN ASTHMA EXACERBATION  
 
Although asthma is classically associated with eosinophilia and Th2 cytokines, some patients 
show a neutrophil-predominant disease with an absence of Th2 cytokines. In particular, 
patients with more severe forms of asthma seem to have neutrophilic inflammation with less 
reversible airway obstruction and a mixed Th1 and Th17 cytokine milieu (mckinley et al. 
2008). The role of IL-17 and Th17 cells in allergic asthma has been fully elucidated, as this 
cytokine has been shown to sometimes be involved in protection and in other cases (most 
cases) with  favours  disease development. Thus, IL-17 can be pro or anti-inflammatory 
cytokine depending on the time point of neutralization or administration of IL-17 for example, 
IL-17A plays a protective role in asthma only during the challenge phase (schnyder-candrian 
et al. 2006).   Another study showed that high exposure to diesel exhaust particles is 
associated with both exacerbated asthma symptoms and increased serum concentrations of IL-
17A in children with atopic asthma (Brandt, E.B et al. 2013). In mice and humans, IL-17 can 
also cause direct contraction of bronchial smooth muscle cells and thus cause bronchial 
hyperreactivity (BHR) in the absence of neutrophilic inflammation.  
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It has been previously demonstrated that IL-17A can exacerbate IL-13 induced AHR (Lajoie 
S, et al. 2010). Other study suggested a contribution of IL-17A to Diesel exhaust particle 
exacerbation of HDM-induced allergic responses (Brandt Eric B et al. 2013). To study 
whether IL-17A is involved in the pathology of allergic airway disease, we examined the 
effects of HDM treated IL-17AF KO mice by a protocol of four times of sensitization and 
challenge periods. Interestingly, IL-17AF KO mice had significantly less AAD than WT 
animals which were identically treated. Moreover, we found that the mixed phenotype of 
neutrophilic/eosinophilic airway inflammation in HDM challenged WT mice switched to an 
attenuated, almost exclusive eosinophilic response in the absence of IL-17. Moreover, 
infection during allergic immune response did not lead to exacerbation of pulmonary 
inflammation in IL-17 KO mice. However, IL-17AF
-/-
 mice did not completely abrogate 
HDM-induced AAD, which suggested that other factors such as Th2 cytokines, drove the 
remaining allergic airway response. Together, our experimental findings indicate that 
pulmonary infection is an essential trigger for IL-17-induced, severe, neutrophilic asthma 
which is refractory to conventional treatment.  
  
 
6.7 TNF- IN ASTHMA 
 
The likelihood that TNF- contributes to the inflammatory response in asthmatic airways is 
supported by observations that TNF- mRNA (Ying et al. 1991a) and protein levels were 
increased in the airways of patients suffering from asthma. Importantly, inhalation of 
recombinant TNF-to normal individuals led to the development of AHR and airway 
neutrophilia (Thomas et al. 1995b; Thomas und Heywood et al. 2002). The mechanisms 
driving TNF- induced AHR have not been fully understood. In addition to its effects on 
AHR, TNF- is a chemoattractant for neutrophils and eosinophils, increases the cytotoxic 
effect of eosinophils on endothelial cells, is involved in activation of T cells, and increases 
epithelial expression of adhesion molecules such as intracellular adhesion molecule (ICAM) 1 
and vascular cell adhesion molecule (VCAM)1.The high amounts of TNF- produced after 
airway infection with M.catarrhalis together with previously reported beneficial effects with 
TNF- blockers in animal models and patients with severe asthma (Curtis und Way et al. 
2009) (Zhang et al. 2009a) prompted us to study the effect of TNF- neutralization under the 
condition pulmonary bacterial infection and consequent exacerbation of allergic airway 
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inflammation.. Our data show that TNF- neutralization was able to largely prevent infection 
induced exacerbation of HDM-allergic reactions despite mild effects on pulmonary 
infiltrations of Th1, Th2 and Th17-producing T cells. While the involvement of TNF-in the 
development of AHR has been supported by several observations (Jatakanon et al. 1999; 
McKinley et al. 2008) (Wang und Wills-Karp et al. 2011), the mechanisms by which this 
cytokine may acts in asthmatic airways are unclear: Besides its effect to induce Rantes and 
IL-6 in human airway smooth muscle cells (Linden et al. 2001), TNF- has also been shown 
to recruit neutrophils and eosinophils (de Vries, Stefan P W et al. 2013a), to enhance T cell 
responses (Essilfie et al. 2012), to mediate glucocorticoid resistance and finally to be involved 
in airway remodelling (Chu et al. 2015). Although, repeated anti-TNF-treatment in our 
model might have led to even lower numbers of pulmonary infiltrates, previous studies have 
shown that despite some clinical benefit, prolonged anti-TNF- therapy was also associated 
with severe infections or development of metaplastic malignancies (Zhang et al. 2009b; 
Rincon und Irvin 2012; Scheller et al. 2011).  
 
Further, we identified IL-17 and TNF-as main mediators of M. catarrhalis triggered   
exacerbation of AHR. Accordingly, ablating or neutralizing of one of the two cytokines was 
sufficient to prevent M. catarrhalis induced exacerbation. However, there is also a complex 
interaction between Th17 cell driven asthma and tumor-necrosis factor (TNF). Pulmonary and 
systemic amounts of TNF are increased in patients with severe steroid-resistant asthma, 
although some studies have not confirmed this (Manni et al. 2014; Berry et al. 2006c).   
Moreover, we are aware that both treatment strategies bear risks, as IL-17 and TNF- have 
been shown to be crucial for the defence against several human pathogens, including 
Streptococcus pneumoniae (Dejager et al. 2015), Pseudomonas aeruginosa (Berry et al. 
2006b), Klebsiella pneumonia (Ying et al. 1991b), Mycobacterium tuberculosis (Bradding et 
al. 1994) and even rhinovirus infections (Thomas et al. 1995a) .  
 
 
 
 
 
 
 
 DISCUSSION 81 
 
SUMMARY 
 
In this study we have demonstrated in a murine model of allergic airway inflammation that 
intranasal infection with the human pathogen M. catarrhalis exacerbate pulmonary 
inflammation.    
The aim of the study was: i) to establish an animal model of infection induced exacerbation of 
lung allergic reactions, ii) to study the pulmonary immune responses of HDM allergic animals 
with and without infection and iii) to identify potential targets to prevent exacerbation of lung 
inflammation. 
The essential findings are that the human pathogen, M. catarrhalis, is able to colonize murine 
lungs for approximately 6 days and thus can be used as a model germ for acute respiratory 
infection. We further could show, that infection with M. catarrhalis exacerbates allergic 
airway inflammation (AAI) via innate and adaptive immune responses, depending on the time 
of infection, i.e. before, during or after established allergic sensitization. While M. catarrhalis 
infection in a non-allergic environment induced high amounts of IL-6 and TNF- but 
moderate amounts of T cell derived IFN- and IL-17, infection triggered exacerbation of AAI 
mainly by IL-17 and TNF- but not IL-6.  
Further, we could show that lack of IL-17 or neutralization of TNF- but not IL-6 is able to 
prevent M. catarrhalis induced exacerbation of AAI.      
 
In conclusion, infection with M. catarrhalis has the potential to exacerbate allergic airway 
inflammation at any time of infection and temporary treatment with anti-IL-17 and/or anti-
TNF-antibodies may be appropriate to prevent aggravation of this lung disease.   
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ZUSAMMENFASSUNG 
 
 
Im Rahmen dieser Arbeit konnte anhand eines Mausmodells für allergische 
Atemwegsentzündung (AAE) gezeigt werden, dass intranasale Infektionen mit 
humanpathogenen M. catarrhalis pulmonale Entzündungsreaktionen verschlimmern kann. 
Ziel der Arbeit war i) die Etablierung eines Tiermodells für infektionsinduzierte Exazerbation 
von pulmonalen, allergischen Entzündungsreaktionen, ii) die Untersuchung pulmonaler 
Immunantworten von HDM-allergischen Tieren mit und ohne Infektionen und iii) die 
Identifikation potentieller Zielstrukturen, um eine Exazerbation pulmonaler 
Entzündungsreaktionen zu verhindern. 
Die wesentlichen Erkenntnisse sind, dass der humanpathogene Keim M. catarrhalis Lungen 
von Mäusen infizieren kann und daher als Modellkeim für akute Atemwegsinfektionen dienen 
kann.  
Weiterhin konnten wir nachweisen, dass M.catarrhalis-Infektionen allergische 
Atemwegsentzündungen abhängig vom Infektionszeitpunkt entweder über angeborene und 
adaptive Immunantworten verschlimmern können. Während eine Infektion mit M.catarrhalis 
in einem nicht-allergischen Umfeld hohe Mengen IL-6 und TNF-, aber moderate Mengen an 
T-Zell produziertem IFN-g und IL-17 hervorruft, induziert die Infektion die 
Verschlimmerung einer AAE hauptsächlich durch IL-17 und TNF-, aber nicht durch IL6. 
Zusätzlich konnten wir zeigen, dass ein Mangel an IL-17 oder die Neutralisation von TNF-, 
aber nicht eine IL-6 Neutralisation, die M. catarrhalis induzierte Exazerbation von AAE 
verhindern kann. 
Zusammengefasst hat eine M. catarrhalis-Infektion das Potential allergische 
Atemwegsentzündungen zu jedem Zeitpunkt der Infektion zu verschlimmern. Eine temporäre 
Behandlung mit anti-IL17 und/oder anti-TNF-Antikörpern  könnte geeignet sein, um eine 
Verstärkung dieser Lungenerkrankungen zu verhindern.
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